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Brain organoids derived from human pluripotent stem cells provide a highly valuable in vitro
model to recapitulate human brain development and neurological diseases. However, the
current systems for brain organoid culture require further improvement for the reliable
production of high-quality organoids. Here, we demonstrate two engineering elements to
improve human brain organoid culture, (1) a human brain extracellular matrix to provide
brain-specific cues and (2) a microfluidic device with periodic flow to improve the survival
and reduce the variability of organoids. A three-dimensional culture modified with brain
extracellular matrix significantly enhanced neurogenesis in developing brain organoids from
human induced pluripotent stem cells. Cortical layer development, volumetric augmentation,
and electrophysiological function of human brain organoids were further improved in a
reproducible manner by dynamic culture in microfluidic chamber devices. Our engineering
concept of reconstituting brain-mimetic microenvironments facilitates the development of a
reliable culture platform for brain organoids, enabling effective modeling and drug develop-
ment for human brain diseases.
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Recent breakthroughs in brain organoid technology haveenabled the development of a new in vitro model thatpromotes significant advancements in the study of nervous
system development and diseases1. Sasai and co-workers pro-
posed the idea that differentiated pluripotent cells can form
multi-layered organized structures that recapitulate embryonic
development when grown in three-dimensional (3D) culture2.
Lancaster et al. developed a 3D culture model termed “cerebral
organoids” that recapitulate many key features of the human
brain in vivo and develop various distinct and interdependent
brain regions3. The generation of cerebral organoids depends on
the intrinsic ability of pluripotent stem cells (PSCs) to sponta-
neously self-organize upon precisely timed manipulation of cul-
ture conditions even in the absence of external patterning
factors3–5. Cerebral organoids representing the whole brain have
significant advantages over brain region-specific2,6–12 or exten-
sively patterned organoids13–17 due to their ability to generate a
diverse range of brain cells and recapitulate the major events in
overall brain development18. Despite the potential of cerebral
organoid technology, there are several challenges. Due to the lack
of instructive signals during the generation of human cerebral
organoids, they recapitulate only some of the earliest stages of
human embryonic brain development5 and are not able to mimic
the later stages of neurogenesis until extended cultivation for
6–9 months19. Another critical limitation is the extensive cell
death in the developing organoids at later stages due to diffu-
sional limitations in oxygen and nutrient transfer4,8.
Several engineering strategies with biomaterials, bioreactors,
devices, and genetic modification have been demonstrated to
overcome such limitations of current brain organoid culture. For
example, synthetic polymer microfilaments enhanced neu-
roectoderm formation and cortical development by facilitating
guided self-organization via neuroepithelium elongation20. In
other study, miniaturized spinning bioreactors were tested for
improving the dynamic culture of brain organoids, which gen-
erated more robust disease models with Zika virus infection8. To
increase the oxygen supply, air–liquid interface culture was
adapted for cerebral organoids, resulting in improved survival
and morphology with extensive axonal outgrowths21. Organ-on-
a-chip systems were also employed to improve the oxygen supply
to the brain organoids22,23. The vascularization of brain orga-
noids by grafting human brain organoids into the mouse brain or
gene editing of vascular transcription factor resulted in pro-
gressive neurogenesis with improved neuronal survival24. Despite
these recent technical improvements, certain progenitor cells still
showed low abundance, and the cytoarchitecture of the basal
zones and cortical layers was not complete3,4. Moreover, the
current protocols based on spontaneous self-organization have
exhibited a significant batch-to-batch variation, which in turn
results in poor reproducibility. Therefore, cerebral organoids still
need to be improved further for neuronal development, structural
maturation, and better electrophysiological functionality, as well
as for ensuring consistent organoid quality.
Here, we propose a strategy to engineer human PSC-derived
cerebral organoids by reconstituting a 3D brain-mimetic micro-
environment with a decellularized human brain tissue-derived
brain extracellular matrix (BEM) and dynamic microfluidic sys-
tems. BEM can recreate brain-mimetic niches necessary to guide
neural and glial differentiation for brain organogenesis, which
would likely be deficient in the non-neuronal matrix (e.g.
Matrigel)25. The application of microfluidic devices capable of
achieving a gravity-driven flow that mimics a fluid flow existing
in the cerebrospinal and interstitial spaces can facilitate the
oxygen supply and nutrient/waste exchange, leading to a sig-
nificant reduction of cell death throughout the structure of
organoids. Thus, we reason that providing brain-specific
extracellular matrix (ECM) cues together with improved nutrient
and oxygen exchange will support cell expansion as well as
neuronal differentiation and functional maturation, thereby
recapitulating prominent features of human embryonic cortical
development in a much precise and reproducible manner.
Results
Characterization of a human brain-mimicking 3D hydrogel
matrix. A bioengineering platform to improve human brain
organoid culture was set up with human brain-mimicking 3D
hydrogel and a microfluidic system. Human cerebral organoids
were generated from human induced pluripotent stem cells
(iPSCs) as described in Lancaster’s protocol (Supplementary
Fig. 1)4. When embryoid bodies (EBs) were induced to develop
into a neuroepithelial lineage at day 11, they were embedded in a
3D matrix supplemented with human BEM (0.4 mg/ml) (Fig. 1a).
Because Matrigel, a common and essential component of the
organoid culture, is refractory to the tissue-specific ECM cues that
are required by different tissue types26,27, modification of
Matrigel-based organoid culture by supplying human BEM would
provide enhanced cell growth and more favorable interactions at
an early stage of neurogenesis. After four days of culture in BEM-
incorporated gel, the organoids were transferred into the micro-
fluidic device under dynamic conditions (Fig. 1a, b). Our
microfluidic platform can allow for independent control of the
cerebral organoids in much smaller medium volume and pre-
cisely controlled medium flow with low fluid shear stress (Sup-
plementary Fig. 2), compared to typical bulk scale bioreactors
(e.g. spinner flasks, orbital shakers) which require larger volumes
and evoke cell damage due to the high shear stress. With the
precisely controlled fluid flow, the effective exchange of oxygen,
nutrients, and bioactive molecules in the medium leads to the
robust expansion and reduced cell apoptosis at an early stage of
organoid development. Consequently, more complex structures
with elongated cortical layers would be evident in cerebral
organoids.
BEM enriched with brain ECM components was prepared by
the decellularization of human brain tissue and subsequent tissue
processing. Human brain samples were pooled before decellular-
ization (Supplementary Table 1). Cellular components in brain
tissue were removed by treatment with a non-ionic detergent
(Supplementary Fig. 3a, b). The decellularization process did not
have a significant effect on the glycosaminoglycan (GAG) content
(Supplementary Fig. 3c). Histological analysis of Hematoxylin
and Eosin (H&E) and Masson’s Trichrome (MT) stained samples
suggested that most of the cells were removed, while collagen, one
of the major ECM components, remained intact after decellular-
ization (Supplementary Fig. 3d). Proteomic analysis of BEM with
mass spectrometry revealed that BEM contains the enrichment of
brain-specific ECM components, including various collagen
subtypes, proteoglycans (e.g. heparan sulfate, neurocan, versican),
and glycoproteins (e.g. laminin, tenascin) (Supplementary
Table 2). Collagens, proteoglycans (e.g. neurocan, versican), and
glycoproteins (e.g. laminin, tenascin)—detected in BEM—can
affect various processes involved in neurogenesis, such as
neuronal polarization and migration, neurite outgrowth, axon
guidance, and synapse development28–31. Thus, BEM can provide
a variety of biological components that influence the development
and function of brain organoids. Rheological analysis of BEM and
Matrigel (Mat) hydrogels identified a higher level of storage
(elastic) modulus than loss (viscous) modulus in all tested
frequency ranges (0.1–10 Hz), indicating the formation of a stable
internal network in both hydrogel systems (Supplementary
Fig. 4a). The average storage modulus of Mat and BEM hydrogels
at 1 Hz was 115.56 ± 5.55 Pa and 126.17 ± 13.52 Pa, respectively
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(Supplementary Fig. 4b), indicating that there is no significant
difference in terms of mechanical properties between these two
hydrogels. These data suggest that the positive effects of BEM
hydrogel on the development of brain organoids are more likely
to be due to the biochemical signals rather than due to
mechanical cues.
The ECM profiles in BEM were compared with those in Mat
and human brain tissue. All identified proteins were categorized
as either ECM or its associated proteins, commonly referred as
‘Matrisome’32–34. We checked ‘Human Protein Atlas’ to examine
whether BEM has comparable ECM profiles to the normal human
brain (Fig. 1c–f). It appears that BEM and human brain tissue
contain a similar percentage of matrisome proteins out of total
proteins (2–5%), whereas majority of proteins in Mat are
matrisomes (~90%) (Fig. 1c). Significant percentages of collagens,
glycoproteins, and proteoglycans are contained in BEM and
human brain tissue, but Mat primarily consists of glycoproteins
(Fig. 1d). We identified 90 ECM proteins in BEM, whereas 747
are found in human brain tissue in Human Protein Atlas
(Supplementary Table 3). We found that 85 out of 90 ECM
proteins (94%) in BEM are expressed in the native brain tissue
(Fig. 1e). The lists of identified proteins in Mat and BEM were
also compared with the list of proteins that are known to show
elevated expression in the human brain tissue at least four-fold
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Fig. 1 Characterization of decellularized human brain-derived extracellular matrix (BEM). a Schematic illustration of the cerebral organoid culture
system with a combination of 3D BEM hydrogel culture and the microfluidic device. b Schematic of the culture protocol for generating cerebral organoids
from human induced pluripotent stem cells (iPSCs) using a brain-mimetic culture system. The developmental stage of organoids is shown at the bottom,
the timeline for each developmental stage is shown in the middle, and the culture condition is shown at the top. c–j Proteomic analysis for the identification
of extracellular matrix (ECM) components in human BEM. The percentages of (c) matrisome proteins out of total proteins, and (d) the subtypes of
matrisome proteins identified in BEM, Matrigel (Mat), and human brain tissue (n= 1 for Mat, n= 3 for BEM). e Total numbers of matrisome proteins
detected in the human brain tissue and BEM. f The number of the brain-enriched proteins by at least 4-fold compared to other organs. g The top 10
biological process terms ordered by p value after gene ontology enrichment analysis of brain-enriched proteins exclusively present in BEM, which are not
detected in Mat. The compositions of (h) matrisome proteins relative to total proteins and (i) the subtypes of matrisome proteins in three batches of BEM
(biological replicates = 3). j Most abundant matrisome proteins found in each batch of BEM. Source data are provided as a Source Data file.
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higher compared to other tissue types35. Only 9 brain tissue-
enriched proteins were found in Mat, whereas 352 proteins were
identified in BEM (Fig. 1f). A gene ontology biological process
(GOBP) analysis indicates that the brain tissue-enriched proteins
only identified in BEM are involved in nervous system
development and neurogenesis (Fig. 1g). Overall, our proteomics
data revealed that the portion and types of matrisome proteins in
BEM are much closer to those of human brain tissue than Mat.
The variability of BEM batches arising from the isolation of
BEM from different sources should be addressed to standardize
the BEM for brain organoid culture. The proteomic analysis of
different batches of BEM showed that portion and compositions
of matrisomal contents are quite similar in three batches of BEM
(batch 1, 2, 3) (Fig. 1h, i). Additionally, the top 10 proteins with
the highest intensity-based absolute quantification (iBAQ) values
completely overlapped in all three batches (Fig. 1j). Although
each batch of BEM was pooled from 2–3 patient samples with
different age and gender, batch-to-batch variability of BEM was
not significant in our study. It was previously reported that brain
ECM composition is altered in cortical dysplasia and temporal
lobe epilepsy36. For example, upregulation of neurocan and
tenascin-C was observed in a murine model of temporal lobe
epilepsy, while major ECMs, such as glycoproteins, laminin, and
fibronectin that are implicated in tissue remodeling, showed no
significant change37. Although the expression of some of the
ECM proteins might be altered in BEM derived from epilepsy
patients, apparent proteins that elicit pathological signals (e.g.
pro-inflammatory cytokines, matrix metalloproteinase-9)37,38
were not identified in our BEM samples. The GOBP analysis of
the total proteins as well as non-matrisome proteins also
suggested that BEM does not contain proteins that are involved
in inflammation (Supplementary Table 4).
BEM increases the neuronal population and enhances neuro-
genesis in the brain organoid. The potential of BEM for pro-
moting brain organoid formation and development of the
neuronal population was investigated. Brain organoids grown in
BEM hydrogel (BEM-incorporated Matrigel) were compared with
those in Mat alone at 30 days of culture. BEM organoids were
significantly larger (p < 0.05) than Mat organoids (1.56 ± 0.44 and
1.84 ± 0.35 mm in diameter for Mat and BEM organoids,
respectively) (Fig. 2a, b). Some samples in the BEM group grew
up to 4–5 mm by 30 days of culture (Fig. 2a, bright-field image).
Immunostaining analysis revealed the presence of laminin-rich
basement membranes at the outer border of the brain organoids
in both the BEM and Mat groups (Fig. 2c, d), which is an
important phenomenon in neocortical development in vivo. The
formation of a laminin layer in BEM organoids was consistently
relatively thicker than in Mat organoids. Although both BEM and
Mat organoids initially formed a laminin-rich basement mem-
brane in early neuroepithelium at day 30 (Fig. 2c), only BEM
organoids maintained a thick laminin basement membrane at day
75 (Fig. 2c). Mat organoids showed only sparse and punctate
signals in laminin staining (Fig. 2c), which indicates that they
failed to maintain the basement membrane upon the generation
and basal migration of neurons3. This observation suggests that
BEM contributed to the maintenance of a laminin basement layer
that could induce the organization of radially aligned neurons in
the cortical layers of the organoids. In the proteomic analysis,
BEM was found to contain more abundant subtypes of laminin
(α2, α4, α5, and β2) than Mat except for α1, β1, and γ1, but Mat
contains approximately 80 times higher relative intensity-based
absolute quantification (riBAQ) values of total laminin subtypes
(0.594 for Mat and 0.007 for BEM) (Fig. 2e). Given that Mat is
much more enriched with laminins than BEM, the thicker
laminin layer formation in the BEM organoids (Fig. 2c, d) is more
likely to be derived intrinsically from the developing organoids
rather than ectopically supplied from BEM.
To examine the generation of the neural population and
neuronal differentiation, the expression of neural progenitor (NP)
markers [Nestin, sex-determining region Y-box 2 (SOX2)] and
neuronal markers [class III beta-tubulin (Tuj1), microtubule-
associated protein 2 (MAP2)] was analyzed (Fig. 2f, g and
Supplementary Fig. 5a, b). The areas positive for Tuj1 and MAP2
were more apparent in the BEM organoids, indicating that BEM
increased the neuronal populations and enhanced neuronal
differentiation in the organoids (Fig. 2f, g). In the BEM organoids,
Tuj1-expressing neuronal cells were present throughout the
whole constructs, whereas a layer of neurons expressing MAP2—
a marker of mature neurons—was mainly located at the basal side
of the ventricle-like structures in the peripheral regions of the
organoids (Supplementary Fig. 5b, c). The apicobasal axis
formation was more evidently observed in brain organoids grown
in BEM hydrogel than in organoids produced in Mat (Fig. 2f and
Supplementary Fig. 5d), suggesting that BEM organoids better
mimicked a distribution of neuronal population showing
apicobasal migration in vivo6. In Mat organoids, smaller
ventricle-like structures were developed, and apicobasal axis
polarity was less frequently observed (Fig. 2f). These collective
observations demonstrated that the exposure of developing
organoids to BEM resulted in the formation of highly dense
ventricle-like structures with few vacant spaces, their integration
into well-organized structures, and enhanced neuronal differ-
entiation with radial polarity.
Compared to organoids cultured in Mat and neurospheres of
human fetal brain-derived neural stem cells (NSCs), human brain
organoids produced in the BEM hydrogel exhibited gene
expression profiles that are indicative of enhanced neurogenesis
(Fig. 2h). As analyzed by quantitative real-time polymerase chain
reaction (qPCR) at 30 days of culture, BEM organoids displayed
approximately two-fold upregulation of an NP marker, SOX2,
compared to Mat organoids and NSCs. The highest expression of
the Enhancer of zeste homolog 2 (EZH2) was found in NSCs, and
the lowest expression was found in Mat organoids. EZH2
involved in stem cell renewal and maintenance is highly
expressed in NSCs or progenitor cells of the cortex, but its
expression decreases in differentiated neurons39–41. The expres-
sion of CDH1—a co-factor that is required for the regulation of
cortical neurogenesis and survival42—was noticeably higher in
the BEM group than in other groups. BEM organoids displayed
the highest TUBB3 (Tuj1) expression, and Mat organoids and
NSCs showed similar levels of TUBB3 expression. The expression
of tyrosine hydroxylase (TH), a dopaminergic neuron marker,
was also the highest in the BEM group. Immunostaining for a
forebrain marker FOXG1 showed that BEM organoids at 75 days
of culture had larger FOXG1+ brain lobules than those in Mat
organoids, suggesting enhanced forebrain identity (Supplemen-
tary Fig. 5e). BEM organoids are likely to have more NPs than
Mat organoids, while undergoing enhanced neurogenesis at the
same time, as indicated by upregulated expression of both
progenitor marker (SOX2) and neuronal marker (TUBB3)
(Fig. 2h). This might be because proliferation and differentiation
of NPs simultaneously occur at early phase of brain organoid
development (~day 30). The rates of proliferation and neurogen-
esis continuously change during brain development, and their
balance is thought to determine the brain size43. Thus, enhanced
proliferation of NPs in BEM organoids may contribute to the
increased size of brain organoids (Fig. 2b).
Surprisingly, an increase in BEM dose did not improve organoid
development (Supplementary Fig. 6). We determined 0.4 mg/ml
BEM concentration as an optimal dose for human brain organoid
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culture. Microscopic observation and immunohistochemical stain-
ing for Tuj1 and SOX2 indicated that higher BEM concentrations
(1 and 2mg/ml) than 0.4 mg/ml BEM did not enhance neuronal
marker expression and neuroepithelial outgrowth in brain
organoids (Supplementary Fig. 6a). qPCR analysis at 30 days of
culture revealed that the expression of neuronal differentiation
markers (Nestin, PAX6, TUBB3, MAP2) was generally higher in
brain organoids grown in 0.4 mg/ml BEM hydrogel than in
hydrogel with other BEM concentrations (Supplementary Fig. 6b).
These data suggest that an optimal concentration of BEM is
required for the development of brain organoids with sophisticated
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BEM increases the radial glial cell population and promotes
cortical layer development in brain organoids. Brain organoids
grown in BEM hydrogel contain a larger radial glial cell (RGC)
population along the ventricular zone (VZ) (Fig. 2i). RGCs
represent a major progenitor pool during early development that
can give rise to neurons and glia, and act as an axis to guide
neuronal migration44,45. RGCs also play a key role in
gyrification46. Immunostaining for radial glial markers phos-
phorylated vimentin (p-Vim), SOX2 and PAX6 at day 30 showed
more densely packed cells in BEM organoids than in Mat orga-
noids (Fig. 2i). The majority of p-Vim+ mitotic radial glial-like
cells were located at the apical surface of the VZ in both Mat and
BEM organoids. In BEM organoids, radial glial-like cells that
extend basal cellular processes toward the outer surface were fre-
quently observed, and some were located above the apical domain,
suggesting basal (or outer) radial glia (Fig. 2i). Mat organoids had
sparse populations of p-Vim+ RG-like cells (Fig. 2i). Furthermore,
a larger number of PAX6+ radial glial progenitor populations were
observed in BEM organoids than in Mat organoids (Fig. 2i). At day
45, BEM organoids displayed formation of more densely populated
CTIP2+ deep-layer above PAX6+ VZ, compared to Mat organoids
(Fig. 2j). This may be due to the presence of an organized layer of
laminin-rich basement membrane in the BEM organoids (Fig. 2c),
which supports cortical layer formation. Immunostaining of brain
organoids cultured for 45 days showed that N-cadherin, which is
involved in the radial migration of multipolar cells47 and main-
taining the normal architecture of the neuroepithelial or RGCs48,
was more highly expressed in BEM organoids than in Mat orga-
noids (Fig. 2j).
To determine whether developing organoids in the BEM
hydrogel could recapitulate the cortical spatial organization, the
organoids were stained for cortical layer markers on days 45 and
75 in the culture. At day 45, the deep layer marked by TBR1+
(cortical layer VI) and CTIP2+ (cortical layer V) neurons started
to express (Fig. 2k). A thicker layer of TBR1+ and CTIP2+
neurons was found in the BEM organoids than in the Mat
organoids at both 45 and 75 days (Fig. 2k). Radial glia gave rise to
intermediate progenitor cells (IPCs) that express TBR2 and move
to the subventricular zone (SVZ)44,45,49. A well-organized layer
containing a mixed population of TBR2+ IPCs and CTIP2+
neurons was reproducibly observed above VZ in the BEM
organoids at day 75 (Fig. 2l). Similarly, a thicker layer containing
CTIP2+ neurons and SATB2+ late-born neurons was observed in
the BEM organoids at day 75 (Fig. 2m). At this stage, the BEM
organoids contained different neuronal subtypes expressing SVZ,
upper- and deep-layer markers that did not show distinguishably
separate layers but given a distribution pattern of dorsal cortical
subtype-specific neuronal populations that resembles in vivo
regional sub-specification, BEM organoids could model the
organization of the neocortex in vivo more closely than the
Mat organoids. Bright-field images revealed more elongated
neuroepithelium structures in the BEM organoids, which was
rarely observed in the Mat organoids (Supplementary Fig. 7a).
The BEM organoids displayed a more complex 3D architecture
with larger cortical layers than the Mat organoids (Fig. 2n and
Supplementary Video 1). The brain organoid culture in BEM
hydrogel induced the significant enlargement of individual
ventricle-like structure thickness as well as the overall volume
of the organoid (Fig. 2o, p). The organization of cortical regions
in the BEM organoids was further confirmed by tissue clearing
using the CUBIC protocol50 and subsequent staining for neuronal
markers (Tuj1, MAP2) (Fig. 2q, r, Supplementary Fig. 7b, c, and
Supplementary Video 2). The elongated neuroepithelial structures
were observed, while maintaining a high density of cells, and
neurons were strongly polarized along their apicobasal axis
(Fig. 2q and Supplementary Fig. 7b, c). BEM organoids contained
much larger lobes than the Mat organoids (Fig. 2r).
BEM elicits the maturation of cerebral organoids at molecular
and functional levels. To further examine the effects of BEM on
Fig. 2 BEM improves neurogenesis and organization of cortical layers in cerebral organoids. a Bright-field images and hematoxylin and eosin (H&E)
staining of Mat- and BEM-embedded brain organoids at day 30 (scale bars = 500 μm for bright-field and 100 μm for H&E staining images, independent
replicates = 3). b Quantification of the longest diameter of Mat and BEM organoids based on the bright-field images of whole organoids (n= 20, Mat
versus BEM p= 0.0349, independent replicates = 3). c Laminin staining of Mat and BEM organoids at 30 and 75 days (scale bars = 100 μm), and (d)
quantification of the thickness of laminin+ basement membrane covering the outer surface of the organoids at day 30 (n= 15 for Mat and n= 12 for BEM,
Mat versus BEM p= 0.0066, independent replicates = 5). e Comparison of relative intensity-based absolute quantification (riBAQ) values of laminin
subtypes identified in Mat and BEM. f Immunohistochemical staining of neural progenitor marker (Nestin) and neuronal markers (Tuj1 and MAP2) at
30 days of culture (scale bars = 500 μm, independent replicates = 1–4). g Image-based quantification of the Tuj1- and MAP2-positive area in the Mat and
BEM organoids at day 30 (n= 10 for Tuj1 and n= 15 for MAP2, Mat versus BEM p < 0.0001 for Tuj1; Mat versus BEM p= 0.0012 for MAP2, independent
replicates = 2–7). h The quantitative real-time polymerase chain reaction (qPCR) analysis to compare gene expression between Mat, neural stem cells
(NSCs), and BEM organoids at day 30 (n= 3 for SOX2, EZH2, and TH and n= 4 for CDH1 and TUBB3, 10–15 brain organoids collected as one sample batch,
Mat versus BEM p= 0.0061, NSC versus BEM p= 0.0027 for SOX2; Mat versus NSC p < 0.0001, NSC versus BEM p= 0.0371 for EZH2; Mat versus
BEM p= 0.0004, Mat versus NSC p= 0.0039, NSC versus BEM p= 0.0001 for CDH1; Mat versus BEM p < 0.0001, NSC versus BEM p < 0.0001 for
TUBB3; NSC versus BEM p= 0.0346 for TH, independent replicates = 3). i Immunohistochemical staining for mitotic radial glia marker phosphorylated
vimentin (p-Vim), SOX2, Nestin, and PAX6, and neuron marker MAP2 in Mat and BEM organoids at day 30 (scale bars = 100 μm, independent
replicates = 6). Note that some p-Vim+/SOX2+ cells are located above the apical domain (white arrowheads). j Immunohistochemical staining for Tuj1
and NeuN at day 30, CTIP2 and PAX6, and N-cadherin (N-Cad) at day 45 in Mat and BEM organoids (scale bars = 100 μm, independent replicates = 2–5).
k Immunohistochemical stained images for deep-layer neuron markers TBR1 and CTIP2 at 45 and 75 days (scale bars = 50 μm, independent replicate = 1).
Immunostaining images for (l) intermediate progenitor marker TBR2 and CTIP2 and (m) superficial-layer neuron marker SATB2 and CTIP2 in 75-day
organoids (scale bars = 50 μm, independent replicate = 1). n Nucleus-stained (Cyto16) light-sheet microscopic images of Mat and BEM organoids at day
75 (scale bars = 500 μm, independent replicates = 5). Quantification of (o) the thickness of ventricle-like structures (n= 30 for Mat and n= 45 for BEM,
Mat versus BEM p= 0.0007) and (p) the total organoid volume (n= 6 for Mat and n= 9 for BEM, Mat versus BEM p= 0.0035) based on nucleus-stained
(Cyto16) light-sheet microscopic images of Mat and BEM organoids at day 75 (independent replicates = 5). q 3D reconstituted images of 30-day BEM
organoids obtained by tissue clearing and subsequent immunostaining for Tuj1 and MAP2 (scale bars = 1 mm, independent replicate = 1). r 3D images of
Mat and BEM organoids stained for Tuj1 and MAP2 after tissue clearing at day 75 (scale bars = 200 μm, independent replicates = 3–5). Mat and BEM
organoids were cultured in a dish on an orbital shaker. All data are expressed as mean ± standard deviation (SD). Statistical differences between the groups
were determined with a two-sided t-test (*p < 0.05, **p < 0.01, ***p < 0.001). Source data are provided as a Source Data file.
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brain organoid development and to compare the developmental
level of BEM organoids with the human brain tissue, an RNA-
sequencing analysis of global transcriptomes was conducted with
three batches of BEM and Mat organoids at 75 days of culture
(Fig. 3). Compared to Mat organoids, 1323 genes were down-
regulated, and 845 genes were upregulated in BEM organoids
(Fig. 3a). We compared organoid transcriptional profiles with
datasets of brain-specific regions of fetal and adult human brains;
three different parts of the human frontal brain and five regions
of the brain, including the cerebellar cortex, hippocampus, cere-
bellum, striatum, and mediodorsal nucleus of the thalamus. A
Pearson correlation analysis of three regions of the frontal cortex
revealed that both the brain organoid groups generally correlated
more closely with the fetal brains (Fig. 3b). In all three regions,
BEM organoids showed stronger correlations with human brains
than the Mat organoids. Similarly, gene expression patterns
related to five other brain regions in the organoids were more
strongly correlated with those in the fetal brains, where BEM
organoids also exhibited higher correlation coefficient values with
human brains than the Mat organoids (Fig. 3c). These findings
suggest that the organoids generally resembled identities of var-
ious human fetal brain regions in the gestational weeks, and BEM
organoids showed a higher correlation with the human brain than
the Mat organoids. Gene ontology (GO) performed to assess the
differentially expressed genes between BEM and Mat organoids
supported the effectiveness of BEM for brain organoid matura-
tion. The GO terms involved in nervous system development,
neurotransmitter secretion, axon, and synapse were significantly
upregulated in BEM organoids (Fig. 3d). These results confirm
our earlier observations by immunostaining and qPCR that BEM
promoted brain development and differentiation of neuronal
populations. Gene set enrichment analysis (GSEA) revealed the
significantly increased expression of gene sets for astrocyte and
oligodendrocyte, both of which start to appear at a later stage
during brain organogenesis, in BEM organoids compared to that
in Mat organoids (Fig. 3e). Interestingly, differentially expressed
genes in developing BEM organoids significantly overlapped with
known risk genes related to schizophrenia, autism, epilepsy, and
stroke (Supplementary Fig. 8). Therefore, brain organoids gen-
erated with BEM might be useful for disease modeling and disease
mechanism studies during human brain development.
Importantly, BEM organoids exhibited improved electrophy-
siological functionality and neurotransmitter response over Mat
organoids. The level of calcium channel activation was examined
in response to glutamate-induced depolarization using a calcium
influx indicator Fluo-4 AM at day 45 (Supplementary Fig. 9a–c).
Upon exposure to glutamate, greater calcium influx changes were
detected in BEM organoids than those in Mat organoids
(Supplementary Fig. 9a, b). The quantification of the influx
intensity indicated more noticeable changes in the cytoplasmic
calcium influx in individual cell populations of BEM organoids
(Supplementary Fig. 9c). The percentage of glutamate-responsive
cells was also much higher in BEM organoids (Supplementary
Fig. 9c), indicating the existence of electrically more functional
neural cell population in the cerebral organoids grown in the
BEM hydrogel. Immunohistochemical analysis for vesicular
glutamate transporter 1 (VGLUT1), an excitatory neuronal
marker, (Supplementary Fig. 9d) indicated that BEM organoids
Fig. 3 The genome-wide transcriptome analysis of 75-day brain organoids. a Heatmap showing the expression of differentially expressed genes (DEG)
between Mat and BEM organoids (n= 3 per group, independent replicate = 1). b, c Heatmaps of Pearson’s correlation analysis of RNA-sequencing
datasets of the Mat and BEM organoids for comparison with published transcriptome datasets of (b) three different human frontal regions across different
stages and (c) five different regions of the brain at fetal and postnatal stages. Values in the heatmaps of Mat and BEM groups dictate Pearson’s correlation
coefficients (PCC). Values in the heatmaps of BEM-Mat indicate the differences in PCC between BEM and Mat groups. d The 35 enriched gene ontology
(GO) terms of upregulated genes in BEM organoids versus Mat organoids (shown in terms of p-values). Numbers on the right-hand side of the bar indicate
the number of DEGs within the GO terms. e The gene set enrichment analysis (GSEA) of the astrocyte and oligodendrocyte probe sets in the BEM group
versus the Mat group. Mat and BEM organoids were cultured in a dish on an orbital shaker. Source data are provided as a Source Data file.
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at 45 days contained VGLUT1+ mature excitatory neurons that
are known to emerge during the second trimester of the neonatal
brain51. In contrast, the Mat organoids contained only a few
VGLUT1+ cells at this stage. To assess the electrophysiological
properties of cells in brain organoids, a whole-cell patch analysis
was performed (Supplementary Fig. 9e, f). A voltage-dependent
tetrodotoxin (TTX)-sensitive sodium current was detected and
action potential (AP) was also evoked with current injections. A
physiologically functional recording was barely observed in the
Mat organoids at the same time point. Specific cell populations in
BEM organoids responded to γ-aminobutyric acid (GABA)
treatment (Supplementary Fig. 9g)8. Glutamate decarboxylase 1
(GAD1)+ GABAergic neurons that produce GABA for inhibitory
neuronal activity were detected in BEM organoids (Supplemen-
tary Fig. 9h). Therefore, our findings demonstrate that BEM
organoids mimic some features of the later developmental stages
of the human brain with more functional neuronal properties
than the control organoids grown in Matrigel. Overall, the
exposure of organoids with neuroectoderm identity to the
complex networks of BEM at an early developmental stage
triggered NP expansion, cortical layer organization, and enhanced
neurogenesis, leading to the structural maturation and functional
improvement of organoids.
The tissue-specific effects of BEM on brain organoid genera-
tion. BEM can provide complex networks of brain-specific ECM
optimal for brain organoid development. The effects of ECM on
lineage specification and organoid development from stem cells
could be tissue-specific. Our previous studies have reported that
the tissue-specific microenvironments provided by a decellular-
ized tissue matrix improved the survival, differentiation, and
function of various types of stem cells, reprogrammed cells, and
primary cells52–56. The biochemical compositions of ECM
hydrogel vary depending on the tissue source from which the
ECM is isolated. Therefore, the tissue-specific effects of BEM for
supporting the development of brain organoids were investigated
by comparing the brain organoid supporting the ability of BEM-
supplemented hydrogel with that of Matrigel incorporated with
ECM derived from other types of tissues, including intestine
(IEM), liver (LEM), and heart (HEM) (Fig. 4). At day 30, the size
of organoids generated in Mat and other tissue-derived ECM
hydrogels was similar (Mat; 1385 ± 255.7 μm, IEM; 1241 ± 319.3
μm, LEM; 1130 ± 327.4 μm, HEM; 1355 ± 431.7 μm), whereas the
brain organoids cultured in the BEM hydrogel were larger in
diameter (BEM; 1723 ± 239.4 μm) than the control groups
(Fig. 4a, c). In addition, BEM facilitated the formation of larger
neuroepithelial structures and increased Tuj1+ neuronal popu-
lations (Fig. 4a, b). Next, the gene expression profiles of the brain
organoids cultured in various matrices at day 30 were compared
(Fig. 4d). The expression of repressor element 1 silencing tran-
scription factor (REST) and DNMT3B—which are known to
suppress neuronal differentiation—was the lowest in BEM orga-
noids among the tested groups. When compared with the orga-
noids in Mat and other ECM control groups, the expression of
neuronal markers TUBB3 and MAP2 was significantly upregu-
lated in the BEM group, demonstrating the neuronal differ-
entiation accelerated by the BEM signals. Overall, these results
prove the critical role and necessity for tissue-specific ECM in
organoid development.
Microfluidic BEM conditions improve the survival of brain
organoids. A low level of fluid flow existing in the cerebrospinal
and interstitial spaces of the brain has been found to play an
essential role in supporting the development of ventricle-like
structures and the formation of the neuronal layers in the cerebral
cortex57. Cerebrospinal fluid circulation induces pulsatile and bi-
directional flow exchange at the blood barrier and the borders
between cerebrospinal fluid and interstitial fluid spaces58,59.
Therefore, we hypothesized that the presence of fluid flow that
mimics the bi-directional cerebrospinal fluid would be able to
amplify the effects of BEM for brain organoid development by
facilitating molecular diffusion in and out of the organoids,
leading to further improvement of neuronal differentiation and
ventricle-like structure formation in developing organoids. Based
on these considerations, a multi-layered chamber microfluidic
device was developed that can generate precisely controlled fluid
flow (Fig. 5a and Supplementary Fig. 2a, b). The device consists of
three layers with five chambers that are fluidically connected by
microchannels, enabling continuous fluid perfusion between the
chambers without the need for external tubing and pumping.
Two chambers are designed for brain organoid cultures and three
chambers for medium reservoirs. Fluid flow through the micro-
channels connecting the chambers could be generated by
hydrostatic pressure created by different medium levels in the
chambers (Supplementary Fig. 2c), which was simply achieved by
placing the device on a bi-directional laboratory rocker. Simula-
tions preceding the design of the device (Supplementary Table 5)
confirmed that our device could mediate the effective transfer of
nutrients, such as glucose, into large organoids embedded in
hydrogels (Supplementary Fig. 10). Four different designs of the
device were simulated; (1) z1-channel model, (2) z3-channel
model, (3) y5-channel model, and (4) y5-z3-channel model
comprising a combination of z3- and y5-channel designs. Based
on the simulation results of glucose transfer under gravity-driven
medium flow, the y5-z3-channel model was adopted as a final
device design for brain organoid culture, which shows more
uniform glucose gradient profiles in the vertical axis (Supple-
mentary Fig. 10a) and greater glucose transfer to the organoids
(Supplementary Fig. 10b). As our approach does not require
complicated settings with pumps and tubing, a large number of
devices could be operated in parallel using a single rocker system.
Thus, large-scale organoid cultures and high-throughput assays
and screening are possible with our device under microfluidic
conditions.
To check whether our device platform can improve molecular
diffusion into organoids, after stabilization of brain organoids in
BEM hydrogel for four days, the organoids embedded in BEM
hydrogel were transferred into a 24-well plate (BEM-plate) or
microfluidic device (BEM-device) on the laboratory rocker
(Fig. 1a). The computational simulation of glucose diffusion
through the brain organoids in the device predicted that at a
given fluid flow, the glucose present in the medium is actively
transferred to the brain organoids, which equilibrated with the
glucose concentration in the medium within 60min of dynamic
culture (Fig. 5b). However, a low level of glucose was diffused into
the organoids in the well plate under static conditions without
medium flow (Supplementary Fig. 11a). Next, intra-organoid
oxygen levels were visualized on day 30 by incorporating oxygen-
sensing phosphor nanoparticles composed of Pt(II) meso-tetra
(pentafluorophenyl)porphine (PtTFPP)-poly(urethane acrylate
nonionomer) (PUAN)60. Higher oxygen levels lead to lower
phosphorescence of the nanoparticles, which is attributed to
collisional quenching between oxygen molecules and PtTFPP
(Supplementary Fig. 11b). When the oxygen-sensing nanoparti-
cles were incorporated in the BEM-plate and BEM-device
organoids on day 30, the normalized mean phosphorescence
intensity of the BEM-plate organoids was more than two-fold
higher than that of the BEM-device organoids (Fig. 5c, d). This
significant difference was more pronounced in the core region of
the organoids. Therefore, our results indicate that the BEM-
device conditions allowed for significantly higher and more
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uniform intra-organoid oxygen levels. This observation together
with glucose diffusion simulation demonstrates that the precise
control of the medium flow at a microscale level may be more
effective for oxygen/nutrient supply and molecular exchange in
organoids than irregular dynamic flow under bulk scale
conditions.
Consequently, BEM-device organoids exhibited higher cell
proliferation and less cell death, and a notably larger size than
BEM-plate organoids (Fig. 5e–j, and Supplementary Fig. 12a–c).
Proliferative cells mainly undergo anaerobic glycolysis converting
glucose into lactate, whereas postmitotic neurons undergo a switch
towards mitochondrial metabolism61. Quantification of metabolite
glucose and lactate at day 30 revealed that BEM organoids
cultured in the device consumed more glucose and secreted more
lactate, compared to those ones cultured in the plates, suggesting
that BEM-device organoids display the metabolic profile of higher
proliferative cells (Fig. 5e, f). By day 45, BEM-plate organoids
maintained the levels of glucose consumption and lactate
production, whereas the levels decreased in BEM-device orga-
noids, which may indicate that cells in BEM-device organoids
switched to differentiation metabolic state. In the BEM organoids
cultured in the device, the neuroepithelium was organized in a
manner reminiscent of the early developing cortex, where cells
positive for the proliferation (Ki67) and NP markers (Nestin) were
abundant at the apical surface of the VZ (Fig. 5g). Compared to
the BEM-plate organoids, the BEM-device organoids contained a
larger number of Ki67+ and Nestin+ cells (Fig. 5h). Significantly
less necrotic areas were found in BEM-device organoids than in
BEM-plate organoids (Fig. 5i, j). When the apoptotic core regions
were analyzed by quantifying the area stained with an active form
of Caspase 3 at day 45 (Fig. 5i), cleaved Caspase 3+ apoptotic cells
were observed in the BEM-plate and BEM-device organoids with
the average area of 12.7 ± 6.2% and 2.9 ± 2.2%, respectively
(Fig. 5j). Only very few numbers of Caspase 3+ cells were found
in the core region of BEM-device organoids. An increase in the
proliferative cell population along with reduced apoptosis in the
BEM-device organoids resulted in noticeably larger organoids
than that in the BEM-plate organoids (Supplementary Fig. 12a, b).
Some BEM-device organoids grew up to 8 mm in diameter by day
60 (Supplementary Fig. 12c). Interestingly, the presence of BEM is
likely to prevent the formation of necrotic clusters that were seen
in Mat organoids (Supplementary Fig. 12d, e). To confirm that the
microfluidic device allows better oxygen supply to the core region
of the organoids, immunohistochemical staining for a hypoxia
marker hypoxia-inducible factor-1α (HIF-1α) was performed at
day 120 (Supplementary Fig. 12f, g). HIF-1α-positive area in the
BEM-device organoids was significantly smaller than that of Mat
and BEM organoids cultured in the plates, indicating that hypoxia
in the organoid core was alleviated by microfluidic culture. These
results support again that the microfluidic device facilitates oxygen
transfer to the core of large organoids, resulting in the prevention
of necrotic core formation via improved cell survival and
decreased apoptosis. BEM-device organoids contained a larger
number of FOXG1+ lobes than BEM-plate organoids (Supple-
mentary Fig. 12h). The periodic application of bi-directional
medium flow in the microfluidic device contributed to improving
the overall quality of the brain organoids. When we examined the
expression of a choroid plexus (CP) epithelial cell marker
transthyretin (TTR) in Mat, BEM, and BEM-device organoids,
all groups were found to contain similar TTR+ area (Supplemen-
tary Fig. 12i, j), suggesting that BEM did not affect CP
development.
Fig. 4 The tissue-specific effects of 3D ECM hydrogels on brain organoid development. a Bright-field images of brain organoids encapsulated in ECM
hydrogels derived from different decellularized organs [brain (BEM), intestine (IEM), liver (LEM), and heart (HEM)] at day 30 (scale bars = 500 μm).
b Immunostaining of brain organoids on day 30 for Tuj1 and SOX2 (scale bars = 500 μm). c Image-based quantification of the longest diameter of brain
organoid at day 30 (n= 10 per group, BEM versus Mat p= 0.0069, BEM versus IEM p= 0.0013, BEM versus LEM p= 0.0002, BEM versus HEM p=
0.0301). d The gene expression analysis of brain organoids at day 30 by qPCR for transcriptional factors (REST, DNMT3B) and neuronal markers (TUBB3,
MAP2) (n= 4 per group, Mat versus LEM p= 0.025, Mat versus BEM p= 0.0009 for REST; Mat versus BEM p= 0.0498 for DNMT3B; Mat versus LEM
p= 0.031, Mat versus HEM p= 0.0085, Mat versus BEM p= 0.0004 for TUBB3; Mat versus LEM p= 0.0017, Mat versus HEM p= 0.0128, Mat versus
BEM p= 0.0003 for MAP2). Mat and BEM organoids were cultured in a dish on an orbital shaker. All quantitative data are expressed as mean ± SD.
Statistical differences between the groups were determined by unpaired two-tailed t-test (*p < 0.05, **p < 0.01, ***p < 0.001). Independent replicates for all
data in (a–d) = 4. Source data are provided as a Source Data file.
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Importantly, the use of a microfluidic device reduced the
variability in the brain organoids grown in BEM hydrogel. The
gene expression profiles of organoids in the BEM-plate and BEM-
device conditions were analyzed using a single organoid for each
group (Fig. 5k). The relative expression of the neuronal markers,
Nestin, TUBB3, MAP2, and oligodendrocyte marker oligoden-
drocyte transcription factor 1 (OLIG1) was higher in the BEM-
device organoid than that in the BEM-plate organoid. Relative to
the BEM-plate organoid, the expression of the anti-apoptotic
marker B-cell lymphoma 2 (BCL2) was upregulated, while that
of the apoptotic marker BCL2-associated X (BAX) was
downregulated in the BEM-device organoid. Additionally, the
variation in gene expression in the BEM-device organoid was
much less than that in the BEM-plate organoid—as indicated by
the lower variation coefficient value—with the exception of
OLIG1 (Fig. 5k). The BEM organoids cultured in multi-well
microfluidic device designed to have 24 chambers for scalable
organoid culture (Supplementary Fig. 13a, b and Supplementary
Video 3) not only displayed relatively higher expression of PAX6
and TUBB3, but also showed significantly less variation in the
expression levels of both genes, compared to the BEM organoids
cultured using conventional plates (Supplementary Fig. 13c–f).
Fig. 5 Microfluidic dynamic culture supports the proliferation and prevents the apoptosis of brain organoids grown in the 3D BEM. a Schematic
diagram of the microfluidic device for the brain organoid culture. b Computational simulation of glucose concentration within the brain organoid and its
surroundings in a culture chamber under the fluid flow conditions (left). Comparison of glucose concentration within the brain organoid in the presence and
absence of fluid flow (right). c Representative merged images showing organoids (gray) and phosphorescence of oxygen-sensing (PtTFPP-PUAN)
nanoparticles at 754 nm (red) for BEM-plate (top) and BEM-device (bottom) organoids on day 30 (scale bars = 200 μm, independent replicates = 4).
d The normalized mean phosphorescence intensity in BEM-plate and BEM-device organoids (n= 3 per group, BEM-plate versus BEM-device p= 0.032,
independent replicates = 4). Measurement of (e) glucose level in organoids and (f) lactate level in the medium at days 30 and 45 (n= 4 for D30 and
n= 5 for D45, BEM-plate versus BEM-device p < 0.0001 at D30 and p < 0.0001 at D45, independent replicates = 2 for day 30 and 1 for day 45).
g Immunostaining for the proliferation marker Ki67 and the progenitor marker Nestin in the BEM-plate and BEM-device organoids (scale bars = 50 μm,
independent replicates = 3). h The quantification analyses of Ki67+ and Nestin+ cells in the BEM-plate and BEM-device organoids (n= 10 for BEM-plate
group, and n= 4 for Ki67+ and n= 7 for Nestin+ in BEM-device group, BEM-plate versus BEM-device p= 0.0004 for Ki67 and p= 0.005 for Nestin,
independent replicates= 3). i Brain organoids stained with ethidium homodimer-1 (EthD-1) to label dead cells at day 30 and cleaved caspase-3 (cCasp3) at
day 45 (scale bars = 500 μm). j Quantification of EthD-1+ and cCasp3+ area per organoid (n= 4 for BEM-plate group, n= 4 for EthD-1+ and n= 3 for
cCasp3+ in BEM-device group, BEM-plate versus BEM-device p= 0.0056 for EthD-1 and p= 0.049 for cCasp3, independent replicates = 3). k Differential
gene expression analyses by qPCR with BEM-plate and BEM-device organoids. One sample was prepared from a single organoid. The coefficient of
variations is dictated above the bars for each group. Data are expressed as violin plots. Dark gray dashed lines and black lines indicate 25–75% quartiles
and median, respectively (n= 19 for BEM-plate group and n= 30 for BEM-device group in all markers except for OLIG1, n= 29 for BEM-plate group and
n= 35 for BEM-device group in OLIG1, BEM-plate versus BEM-device p= 0.0102 for NES, p < 0.0001 for TUBB3, p= 0.0001 for OLIG1, p < 0.0001 for BCL2,
and p < 0.0001 for BAX, independent replicates = 4). All analyses were performed over 30 days in the culture. All data are expressed as mean ± SD,
otherwise stated separately. Statistical differences between the groups were determined by unpaired two-tailed t-test (*p < 0.05, **p < 0.01, ***p < 0.001
versus BEM-plate group). Source data are provided as a Source Data file.
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Taken together, these results demonstrate that the microfluidic
organoid culture platform increased neuroepithelial outgrowth
and overall organoid size by promoting cell proliferation and
reducing apoptosis and necrotic cluster. In addition, the
microfluidic BEM condition might reduce the variation between
organoid samples in terms of gene expression profiles, thereby
improving the homogeneity of brain organoids that is critically
important for precise evaluation and data interpretation during
drug testing and disease modeling.
The microfluidic BEM platform enhances corticogenesis and
radial glial cell generation in brain organoids. Enhancement of
organoid growth and cortical structure formation by microfluidic
BEM culture was assessed by 3D light-sheet microscopy and
subsequent morphological analysis (Fig. 6a–c). Microfluidic cul-
ture improved oxygen supply to the interior of the organoids that
leads to increased proliferation, expanded NP population, and
thicker neuroepithelium. Accordingly, the microfluidic BEM
device induced significantly faster growth and development of
more complex surface structure in brain organoids than the
control culture conditions (Mat-plate, BEM-plate) (Fig. 6a, b).
The overall volume of organoids in Mat-plate, BEM-plate, and
BEM-device groups was 0.14 ± 0.02 mm3, 0.31 ± 0.14 mm3, and
0.56 ± 0.17 mm3, respectively, indicating a marked difference
between the groups (Fig. 6c). The degree of sphericity was 0.57 ±
0.03, 0.47 ± 0.14, and 0.35 ± 0.11 in Mat-plate, BEM-plate, and
BEM-device organoids, respectively (Fig. 6d). Mat organoids were
found to be morphologically smoother and smaller relative to the
BEM organoids (Fig. 6a–d). The sectioned, nuclei-stained images
obtained by confocal microscopy also showed larger and more
elongated lobes in the BEM organoids compared to that in the
Mat organoids (Supplementary Fig. 14a). These results suggest
that BEM promoted volume expansion, structural maturation,
and the formation of the elongated epithelium in organoids, and
microfluidic devices magnified these effects of BEM by providing
favorable dynamic microenvironments for the brain organoid
cultures. Overall, BEM combined with a microfluidic system
facilitated organoid growth and induced a high level of cellular
accumulation, leading to the formation of highly complex and
more advanced structural developments62.
The efficient supply and exchange of nutrients/oxygen by well-
controlled bi-directional fluid flow promoted NP proliferation
with the expansion of radial glia during the early stage of brain
organogenesis. In BEM-device organoids, the increase in
proliferation coincided with an expansion of the NP pool, as
shown by immunostaining for radial glia markers p-Vim, SOX2,
and PAX6 (Fig. 6e and Supplementary Fig. 14b, c). The larger
number of p-Vim+ mitotic RGCs was detected in the BEM-
device organoids than that in BEM-plate organoids (Fig. 6e and
Supplementary Fig. 14d). At 30 days, some of the p-Vim+ and
PAX6+ NPs showing a typical radial glial morphology with
processes contacting both the apical and basal surfaces of the
neuroepithelium were observed in the BEM-device organoids
(Supplementary Fig. 14c). Cortical layer formation in vivo
depends upon the proper migration of postmitotic neurons from
their sites of origin to their final destinations, and neuronal
migration is preciously orchestrated by various intrinsic and
extrinsic factors63,64. The presence of Cajal-Retzius cells, which
are involved in neuronal migration and cortical lamination64,65,
was examined by immunostaining for Reelin in the BEM-device
organoids at day 30 (Fig. 6f). The sectioned organoid images
stained for Reelin revealed a wide distribution of Reelin+ signals
in the most superficial regions (Fig. 6f, left panel). The 3D
imaging analysis indicated more dispersed signals of Reelin as a
secreted factor (Fig. 6f, right panel). Therefore, the enrichment of
the cell types and their roles supporting cortical layer formation
in BEM-device organoids was speculated.
As a result, the microfluidic BEM system significantly
promoted corticogenesis in developing brain organoids. The
expression of a deep-layer marker TBR1 in organoids at day 30
was examined by confocal microscopy (Fig. 6g–i). Compared to
Mat organoids, the BEM organoids contained an increased
TBR1+ cell population (Fig. 6g, h). TBR1 expression with a
broader spectrum of the z-axis along the cortical layer was
detected in the BEM-device organoids (Fig. 6i and Supplementary
Fig. 15a, b). BEM-device organoids formed a thicker deep layer
containing CTIP2+ and TBR1+ neurons at day 45 (Fig. 6j). In
addition, a thicker layer of TBR2+ cells with a highly packed band
of cells in the cortical region of the BEM-device organoids was
also observed at day 45 (Fig. 6k), indicating that the formation of
the SVZ layer with a high density of cells was promoted in brain
organoids cultured under BEM-device conditions. Chondroitin
sulfate proteoglycan (CSPG)+ layer indicating preplate splitting
was observed in BEM-device organoids (Supplementary Fig. 15c).
BEM and BEM-device organoids displayed a mixed population of
deep-layer marker CTIP2+ neurons and upper-layer marker
SATB2+ neurons 75 days of culture (Fig. 6l). Compared to BEM
organoids, a substantially thicker layer of SATB2+ neurons was
formed in the BEM-device organoids (Fig. 6l). Both BEM and
BEM-device organoids contained SOX2+ and HOPX+ basal
radial glia-like populations at day 75. A SOX2+/HOPX+ outer
SVZ structure separated from SOX2+/HOPX− VZ was more
frequently observed in the BEM-device organoids (Fig. 6m).
BEM-device organoids innately developed a higher population
of ionized calcium-binding adaptor molecule 1 (IBA1)+ and
CD68+ microglia (Supplementary Fig. 16a, b). IBA1+ microglia
were initially found sparse in small clusters at day 30, but IBA1+
and CD68+ cells were present throughout the BEM-device
organoids at day 74. Quantification of microglial population in
Mat, BEM, and BEM-device organoids at day 74 indicated the
highest numbers of IBA1+ and CD68+ microglia in the BEM-
device organoids (Supplementary Fig. 16c, d). By day 60, the
BEM-device organoids showed a higher density of Tuj1 and
mature neuronal marker VGLUT1 or presynaptic marker
Synapsin I (SYNI) co-positive cell populations than BEM-plate
organoids (Fig. 6n, o). At this time point, only BEM-device
organoids expressed a mature synaptic marker, postsynaptic
density protein 95 (PSD95) (Supplementary Fig. 16e). In addition,
glial fibrillary acidic protein (GFAP)+ astrocytes, which are
detected in the late stages of brain organogenesis, were more
abundantly present in BEM-device organoids (Fig. 6p). The
combination of BEM with a microfluidic system facilitated the
maturation of neural populations in brain organoids even without
exogenous neurotrophic factors in a relatively short period.
Overall, bioengineering organoid culture with brain ECM- and
cerebrospinal fluid-mimetic cues increased populations of pro-
liferative progenitors and Reelin-secreting Cajal-Retzius cells,
resulting in a robust organoid growth and accelerated cortical
layer organization along the radial axis that contains mature
neurons and glial cells. This contributes to the formation of
elongated and continuous cortical layers and increases the
complexity of the structures.
The further maturation of brain organoids at the molecular
and functional levels by micro-controlled fluid flow. The
microfluidic BEM system facilitated the further maturation of
brain organoids in terms of transcriptome profiles and electro-
physiological properties. To investigate the effects of microscale
dynamic flow on the transcriptome profiles in brain organoids,
RNA-sequencing was performed with three batches of BEM-plate
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and BEM-device organoid samples at day 75 (Fig. 7a–c and
Supplementary Fig. 17). A heatmap of the differential expression
analysis showed that 214 genes were upregulated and 802 genes
were downregulated in BEM-device organoids compared with
that in the BEM-plate organoids (Supplementary Fig. 17a).
Pearson’s correlation coefficient values between samples in the
same group and principal component analysis (PCA) demon-


















































































































































































































Fig. 6 Bioengineering of the brain organoids by the microfluidic BEM system improves radial glial generation and cortical organization. a Light-sheet
microscopic bright-field images of 3D brain organoids encapsulated in Mat and BEM cultured in a plate or microfluidic device at 60 days of culture (scale
bar = 500 μm, independent replicates = 3). b Reconstructed light-sheet microscopic images of 60-day Mat-plate, BEM-plate, and BEM-device organoids
(scale bar = 500 μm, independent replicates = 3). c Quantification analyses for the 3D organoid volume (n= 3, 9, and 13 for Mat-plate, BEM-plate, and
BEM-device groups, respectively, Mat-plate versus BEM-device p= 0.0007, BEM-plate versus BEM-device p= 0.0014, independent replicates = 3), and
(d) sphericity (n= 3 per group, independent replicates = 3) of brain organoids using IMARIS software. e Representative immunostaining images for
mitotic radial glia marker phosphorylated vimentin (p-Vim) and SOX2 in the BEM-plate and BEM-device organoids at day 30 (scale bar = 50 μm,
independent replicates = 5). f Expression of the radial glial marker PAX6 and extracellular glycoprotein marker Reelin in BEM-device organoids (left
panel, scale bars = 200 μm, independent replicates = 2) and 3D imaging of Reelin expression in BEM-device organoids at day 30 (right panel, scale bars =
200 μm, technical replicates = 5). g 3D plotting and (h) quantification of deep-layer marker TBR1-expressing cells in Mat-plate, BEM-plate, and BEM-
device organoids at day 30 using IMARIS software (n= 3 for Mat-plate and BEM-plate groups, and n= 4 for BEM-device group, independent replicates =
3). i 3D plotting analysis of TBR1+ cells in BEM-device organoids on different z-positions in the radiometric color spectrum (scale bar = 200 μm,
biological replicates = 3). j Immunohistochemically stained sections for TBR1 and CTIP2 at day 45 (scale bar = 50 μm, independent replicate = 1).
k Immunohistochemical staining images for subventricular marker TBR2 and PAX6 at day 45 (scale bar= 50 μm, independent replicates = 2). Pink color in
the pie-charts indicates the number of cortical structures with separated layers of TBR2+ and PAX6+ cells, and grey color indicates no layer preferences.
l Immunostaining images showing CTIP2 and superficial-layer neuron marker SATB2 (scale bars = 50 μm, independent replicate = 1), and (m) basal radial
glia marker SOX2 and HOPX at day 75 (scale bars = 50 μm, independent replicate = 1). n Immunostaining of Tuj1 and glutamatergic neuron marker
VGLUT1 (independent replicates = 2), (o) presynaptic marker SYNI (independent replicates = 2), and (p) astrocyte marker GFAP in the BEM-plate and
BEM-device organoids at day 60 (scale bars = 100 μm, independent replicates = 3). All data are presented as mean ± SD. Statistical differences between
the groups were determined with unpaired two-tailed t-test (**p < 0.01, ***p < 0.001). Source data are provided as a Source Data file.
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BEM-device group than in those in the BEM-plate group
(Fig. 7a). GO analysis identified the enrichment of neuronal
differentiation, axonal guidance, and neuronal migration among
upregulated genes in the BEM-device group compared to the
BEM-plate group (Fig. 7b). Especially, the expression of genes
involved in mediating the cellular response to hypoxia and cell
proliferation increased (Fig. 7c). GSEA analysis showed that genes
involved in apoptosis were enriched in the BEM-plate group
(Supplementary Fig. 17b). These results coincide with the earlier
observation that bi-directional fluid flow generated by our
microfluidic platform could provide higher oxygen content for
the organoids, leading to increased cell expansion and decreased
apoptosis. BEM-device organoids also showed upregulated
expression of risk genes related to schizophrenia, autism, and
Parkinson’s disease, compared with BEM-plate organoids (Sup-
plementary Fig. 17c).
Improvement of the electrophysiological functional properties
of cells in brain organoids by microfluidic 3D BEM culture with
the dynamic flow was assessed by calcium influx imaging and a
whole-cell patch-clamp recording at 75 and 60 days of culture,
respectively. Cells that responded to glutamate in BEM-device
organoids showed a more significant increase in intracellular
Ca2+ levels, compared with those in the BEM-plate organoids
(Fig. 7d). A few cells in the BEM-device organoids exhibited
spontaneous spikes of Ca2+ influx, even in the absence of any
neurotransmitters (Fig. 7e and Supplementary Video 4). An
electrophysiological study using whole-cell patch clamping
demonstrated that recorded neurons in both organoid groups
showed Na+ currents in response to voltage steps (Fig. 7f). The
average amplitudes of Na+ currents in response to voltage ramps
between −30 mV and 20mV were much higher for neurons in
BEM-device organoids than those in BEM-plate organoids
(Fig. 7g). Neurons in both organoid groups were capable of
eliciting APs in response to depolarizing current injection, which
are similar to those of mature functional neurons (Fig. 7f).
Neurons in BEM-device organoids were able to produce APs at a
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Fig. 7 The transcriptome profile analyses and electrophysiological function characterization of brain organoids cultured in the microfluidic BEM
system. a Pearson’s correlation matrix for whole-genome profiles in BEM-plate and BEM-device organoids (n= 3, independent replicate = 1). Pearson’s
correlation coefficient (PCC) values are indicated in each box. b The top 14 enriched gene ontology (GO) terms of upregulated genes in the BEM-device
group versus the BEM-plate group (shown in terms of p values). c Lists of differentially upregulated genes classified in two GO functional categories;
‘Cellular response to hypoxia’ and ‘Cell proliferation’. d Ratiometric images of calcium imaging before and after 100 μM glutamate treatment in Fluo-4 AM-
loaded BEM-plate and BEM-device organoids (scale bars = 50 μm, independent replicates = 4). The color scale indicates fluorescence intensity of Fluo-4
AM. e A fluorescence image showing spontaneous calcium (Ca2+) transient of cells in BEM-device organoids (left) (scale bar = 100 μm, independent
replicates = 3). Representative time-course peaks showing spontaneous changes in Fluo-4 AM fluorescence intensity measured in cells in the BEM-device
organoid (right). Traces were obtained from the region of intensity (ROI) marked on the fluorescence image. f Representative current traces recorded in a
neuron with a voltage-clamp mode (left two panels) and representative traces of evoked action potentials (APs) recorded in a neuron with a current-clamp
mode (right two panels) in brain organoids grown in either a BEM-plate (top panels) or a BEM-device (bottom panels). g Quantification of sodium (Na+)
currents in response to increased voltage steps starting from −30 mV to +20mV (10mV step size) in neurons within brain organoids grown in either a
BEM-plate or a BEM-device (n= 5). h Quantification of AP incidence (BEM-plate: n= 27; BEM-device: n= 39, independent replicates = 7), spike numbers
(single versus multiple) in each condition, and threshold potentials to evoke AP (BEM-plate: n= 19; BEM-device: n= 33, unpaired two-tailed t-test (*p <
0.05), BEM-plate versus BEM-device p= 0.0380). Brain organoids cultured for (a–e) 75 days and (f–h) 60 days were analyzed. All data are expressed as
mean ± SD. Source data are provided as a Source Data file.
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higher rate, and higher percentages of these cells fired multi-
spikes of APs compared to those in BEM-plate organoids
(Fig. 7h). The threshold levels of APs were also increased in
BEM-device organoids (Fig. 7h). Importantly, a postsynaptic
current (PSC) was detected only in the BEM-device organoids,
even though this was rare, indicating the formation of a
postsynaptic compartment and the possible establishment of
synaptic networks (Supplementary Fig. 18). Our results support
that the organoid culture in microfluidic BEM condition could
improve the electrophysiological functional properties of brain
organoids. Overall, a precise perfusion culture of human cerebral
organoids in our customized bioreactor based on a microfluidic
device platform facilitated the efficient exchange of nutrients,
oxygen, and waste, leading to volumetric expansion with complex
structures, and further improvement in corticogenesis and
electrophysiological functionalities of individual neuronal
populations.
Reproducible improvement in brain organoid development by
microfluidic BEM platforms. We examined whether micro-
fluidic BEM culture supports reproducible generation of brain
organoids exhibiting improved neurogenesis and structural
maturation. To this end, neurogenesis of BEM-device organoids
was directly compared with that of BEM organoids (in petri dish)
cultured using the standard conventional orbital shaker method.
At day 30, BEM organoids cultured in dish on the orbital shaker
and BEM-device organoids had approximately 1.2 times higher
number of SOX2+ NPs than Mat organoids in dish on the orbital
shaker (Fig. 8a, b). At day 45, BEM-device organoids contained
substantially higher number of NeuN+ neurons compared to
organoids in other two groups cultured with an orbital shaker
(Fig. 8a, c). BEM-device organoids also displayed significantly
larger PAX6+ ventricle-like structures than orbital shaker-
cultured organoids (Fig. 8a, d). At day 60, the presence of the
thickest layer of CTIP2+ deep-layer neurons and the largest area
of VGLUT1+ excitatory neurons were observed in the BEM-
device organoids (Fig. 8a, e, f). We reproducibly observed that the
use of microfluidic device reduces the variation in the size of
brain organoids derived from iPSCs with different passage
numbers as indicated by the lowest coefficient of variation in the
BEM-device organoids (Supplementary Fig. 19).
In addition, the effects of BEM and microfluidic device were
further confirmed by generating organoids using another iPSC
line (KYOU-DXR0109B, ATCC) (Supplementary Fig. 20). When
BEM-device organoids were directly compared with Mat and
BEM organoids cultured on an orbital shaker, similar features of
BEM-device organoids, including faster growth, substantially
longer diameter, and increased neuronal marker expression, were
reproducibly observed with the new iPSC line. Combination of
BEM and microfluidics enhanced neurogenesis during the
development of brain organoids derived from new cell line, as
indicated by more densely packed SOX2+ NPs at the apical side
at day 30 (Supplementary Fig. 20a), and thicker CTIP2+ deep
layer and SATB2+ superficial-layer neurons observed at day 60
(Supplementary Fig. 20b). SATB2+ neurons were barely observed
in Mat and BEM organoids at this time point (Supplementary
Fig. 20b). BEM-device organoids from the new iPSC line at day
60 were also notably larger than Mat and BEM organoids without
microfluidic culture, while showing the reduced variation in the
organoid size (Supplementary Fig. 20c). The expression of several
neuronal markers was significantly elevated in the BEM-device
organoids compared to Mat and BEM organoids at day 60
(Supplementary Fig. 20d). These data validate the reproducibility
of our culture system based on BEM and microfluidics for reliable
production of human brain organoids, irrespective of iPSC lines.
Specialized basal radial glia (bRG) in the SVZ is an important
hallmark of human cortical development. To analyze the
distribution of cortical multi-layer neuronal subtypes in SVZ
layer development, we conducted the immunostaining for several
markers (TBR2, SOX2, HOPX) in the Mat, BEM, and BEM-device
organoids 100 days of the culture (Fig. 8g, h). We observed outer
SVZ-like structures containing HOPX+ bRG-like cells (Fig. 8g).
The number of SOX2+ HOPX+ bRG-like cells substantially
increased in the BEM and BEM-device organoids in comparison
to Mat organoids (Fig. 8g, k). The highest populations of SOX2+
HOPX+ bRG-like cells were found in the BEM-device organoids.
In the BEM-device organoids, we also observed SOX2+ HOPX+
region clearly separated from the SOX2+ HOPX- VZ region
(Fig. 8g). A thin SOX2- HOPX- layer appeared between these two
regions, indicating an inner SVZ-like region (Fig. 8g). At day 100,
Mat organoids contained a layer of a mixed population of TBR2+
cells and CTIP2+ neurons showing no layer preferences (Fig. 8h).
In contrast, BEM and BEM-device organoids displayed CTIP2+
cortical plate-like layer that was formed above TBR2+ SVZ-like
layer (Fig. 8h). The highest number of TBR2+ IPCs was observed
in the BEM-device organoids among all groups (Fig. 8h, l). The
CTIP2+ layers were significantly thicker in BEM and BEM-device
organoids than in Mat organoids (Fig. 8m). These results
demonstrate that BEM enhances the number of bRG-like cells
in the SVZ layer and the microfluidic device improves the
formation of multi-layer progenitor zones.
Co-staining of the brain organoids for upper-layer marker
SATB2 and deep-layer marker CTIP2 on day 100 showed that all
groups contained partially separated layers of early born CTIP2+
neurons and late-born SATB2+ neurons (Fig. 8i), suggesting a
layer specification of deep and upper layers. Thicker CTIP2+ and
SATB2+ layers were found in the BEM and BEM-device
organoids compared to Mat organoids (Fig. 8i, m, n). In the
BEM-device organoids, the thickness of the superficial layer was
more consistent and the distribution of SATB2+ neurons was
localized more superficially to the CTIP2+ neurons by day 120
(Fig. 8j). Accordingly, this two-layer separation became more
distinct in BEM-device organoid by day 120 (Fig. 8j). These data
support that the culture of brain organoids using BEM and
microfluidic device facilitates the development of upper-layer
neurons as well as deep-layer neurons.
The feasibility of porcine BEM for culturing human brain
organoids. We explored the feasibility of porcine brain tissue-
derived BEM (pBEM) for brain organoid culture. Human sources
may be more desirable for human brain organoids but due to a
limited availability, application of BEM derived from porcine
brain tissues, which can be prepared from the same donor con-
ditions (e.g. brain regions, donor ages, etc.), may be a more
preferred option in terms of standardization (Supplementary
Fig. 21a–h). Proteomic analysis of cortex-derived pBEM con-
firmed similar numbers and profiles of matrisomal contents to
those of human BEM (Supplementary Table 2). pBEM was found
to have higher content of glycoproteins and less proteoglycans
compared to human BEM, but the overall profiles of matrisome
compositions were similar (Supplementary Fig. 21c–h). pBEM
contained 457 brain tissue-enriched proteins, and GOBP analysis
revealed that these proteins are involved in synapse signaling,
nervous system development, and neurogenesis (Supplementary
Fig. 21b). Brain organoid culture using pBEM and microfluidics
showed similar improvement as seen in human BEM-based cul-
ture (Supplementary Fig. 22). Combination of pBEM and
microfluidics promoted organoid growth, and increased the
populations of PAX6+ progenitors, CTIP2+ and NeuN+ neurons
at 60 days of culture (Supplementary Fig. 22a–f). Gene expression
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analyses by qPCR indicated higher neuronal gene expression
(PAX6, TUBB3, and MAP2) in pBEM and pBEM-device orga-
noids compared to Mat organoids (Supplementary Fig. 22g).
These results may suggest that pBEM is comparable to
human BEM.
We also examined (1) batch variation (different pBEM batches
derived from the same donor), (2) sample variation (pBEM
samples derived from different donors), and (3) region variation
(pBEM derived from different brain regions). The content and
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cortex of the same donor were similar between different
preparation batches of pBEM (porcine A cortex #1 versus
porcine A cortex #2) (Supplementary Fig. 21c, d). In addition, the
top 10 matrisome proteins with the highest expression completely
overlapped between different batches of pBEM (red highlighted)
(Supplementary Fig. 21e). The variability of pBEM derived from
porcine brain cortical tissues of different donors was then
investigated (porcine A cortex versus porcine B cortex). The
content and composition of matrisome proteins were similar, and
9 out of the top 10 proteins with the highest expression were
matched (Supplementary Fig. 21f–h). When the ECM profiles of
pBEM derived from different brain regions were compared
(cortex versus cerebellum), the content and composition of
matrisome proteins in pBEM prepared from cerebellum were
different from those in pBEM derived from cortex (Supplemen-
tary Fig. 21i, j). Cerebellum-derived pBEM contained higher
content of matrisome proteins (~18%) than cortex-derived pBEM
(~8%). However, both samples shared 8 out of 10 proteins in the
top 10 proteins with the highest expression (Supplementary
Fig. 21k). A heatmap of Spearman’s rank correlation coefficients
and PCA plot of all samples confirm higher degree of similarity in
the pBEM derived from the same brain regions, regardless
different batches or donor samples. (Supplementary Fig. 21l, m).
There was less similarity between pBEM derived from cortex and
cerebellum. Volcano plots of matrisome proteins identified in
cortex pBEM versus cerebellum pBEM also demonstrate the
substantial numbers of differentially expressed proteins (52 out of
108 matrisome proteins differentially expressed by ≥ 2 folds with
p < 0.05) in both types of pBEM samples (Supplementary
Fig. 21n). When we compared cerebral brain organoids cultured
in porcine cortex- and cerebellum-derived pBEM hydrogels,
interestingly they showed differential effects on the development
of FOXG1+ forebrain regions. Brain organoids grown in
cerebellum pBEM displayed smaller FOXG1+ area than orga-
noids cultured in cortex pBEM, which was comparable to Mat
organoids (Supplementary Fig. 23a, b), indicating that cerebellum
ECM is not effective for forebrain region development. Therefore,
BEM derived from different brain regions may affect the
compositions of developing brain regions in the cerebral
organoids.
Overall, proteomic analysis demonstrates that the ECM profile
variation arising from different brain regions exists, but the
batch-to-batch variation from BEM preparation and different
donor samples is relatively low in the case of BEM derived from
the same brain region. Given that porcine tissues with varied ages
are available and also not strictly limited to specific brain regions,
pBEM derived from porcine brain tissue may be able to provide a
reliable source for standardization and practical applications in
brain organoid culture.
Combination of microfluidic BEM culture platform with other
advanced brain organoid protocols. Finally, we tested a com-
bination of microfluidic BEM platform with other advanced brain
organoid protocols. Previously, the original cerebral organoid
protocol could be improved by using poly(lactide-co-glycolide)
(PLGA) fiber scaffolds and treating with short pulses of
CHIR9902120. Thus, we combined our platform with PLGA
microfilament-engineered cerebral organoid (enCOR) method by
encapsulating PLGA-incorporated EBs into BEM hydrogel and
culturing the constructs in our microfluidic device (enCOR-BEM-
device) (Supplementary Fig. 24). We observed higher SOX2+
progenitor population at day 30 and higher number of NeuN+
neurons at day 50 in the enCOR-BEM-device organoids than in
the enCOR-Mat organoids or enCOR-BEM organoids. Although
these preliminary data may indicate a potential of our micro-
fluidic BEM system to be integrated with enCOR method, more
in-depth investigation would be required to check epithelium
elongation and cortical layer development. For the improvement
of generating region-specific organoids, our platform may also
be combined with region-selective differentiation culture
methods6,8,66,67 by supplementing BEM in the medium instead of
Mat and culturing the constructs under the microfluidic device at
a later stage.
Discussion
Here, we develop a brain-mimetic 3D organoid culture platform
by combining two basic tissue-engineering elements; matrix
(human brain tissue-derived ECM) and bioreactor (microfluidic
chamber device). This combination aims to solve problems of
current organoid culturing, which have hindered the practical
application of brain organoids for disease modeling and drug
screening, by providing brain-specific ECM cues and a precisely
controlled brain fluid-mimetic dynamic environment. The
Fig. 8 Combination of BEM and microfluidic device reproducibly improves organization of progenitor zones and cortical layers in brain organoids.
a Immunostaining of Tuj1 and SOX2 (day 30), NeuN, PAX6, and CTIP2 (day 45), CTIP2 and VGLUT1 (day 60) in Mat, BEM, and BEM-device organoid
groups (scale bars = 100 μm, independent replicates = 2). Quantification of (b) SOX2+ cells at day 30 (n= 15 for Mat and BEM groups and n= 7 for
BEM-device group, Mat versus BEM p= 0.003, independent replicates = 3), (c) NeuN+ cells at day 45 (n= 5 for Mat and BEM-device groups and n= 6
for BEM group, Mat versus BEM p= 0.0022, Mat versus BEM-device p < 0.0001, BEM versus BEM-device p= 0.0004, independent replicates = 2), (d)
PAX6+ ventricle-like structure perimeter at day 45 (n= 10 for Mat group, and n= 7 for BEM and BEM-device groups, Mat versus BEM p= 0.0357, Mat
versus BEM-device p= 0.0036, independent replicates = 2), (e) CTIP2+ layer thickness at day 60 (n= 5 for Mat and BEM groups, and n= 4 for BEM-
device group, Mat versus BEM p= 0.0243, Mat versus BEM-device p= 0.0047, independent replicates = 2), and (f) VGLUT+ cell area at day 60 (n= 4,
Mat versus BEM-device p= 0.0258, independent replicates = 2). g Immunostaining of basal radial glia markers SOX2 and HOPX at day 100 (scale bars =
100 μm for white line and 20 μm for yellow line, independent replicates= 2). Note the SOX2+/HOPX+ outer subventricular (SVZ) region clearly separated
from the SOX2+/HOPX- ventricular zone (VZ)-like region in BEM-device organoid. Immunostaining of (h) SVZ marker TBR2 and deep-layer marker CTIP2
at day 100 (scale bar = 100 μm, independent replicates = 2), and (i, j) upper-layer marker SATB2 and CTIP2 at (i) day 100 (scale bar = 200 μm,
independent replicates = 2) and (j) day 120 (scale bar = 200 μm, independent replicates = 2) in Mat and BEM organoids cultured in the petri dish on the
orbital shaker, and BEM-device organoids cultured in the microfluidic device on the bi-directional rocker. Quantification of (k) SOX2+/HOPX+ cells (n = 6
for Mat group, and n= 7 for BEM and BEM-device groups, Mat versus BEM-device p= 0.0008, independent replicates = 2), l TBR2+ intermediate
progenitor cells (n= 7 for Mat and BEM-device groups, and n= 8 for BEM group), Mat versus BEM p= 0.0147, Mat versus BEM-device p= 0.0005, BEM
versus BEM-device p= 0.0101, independent replicates = 2), (m) the thickness of CTIP2+ deep-layer neurons at day 100 (n= 7 for Mat and BEM groups,
and n= 4 for BEM-device group, Mat versus BEM p= 0.0004, Mat versus BEM-device p= 0.0001, independent replicates = 2), and (n) the thickness of
SATB2+ superficial-layer neurons at day 100 (n= 7 for Mat and BEM groups, and n= 4 for BEM-device group, Mat versus BEM p= 0.0003, Mat versus
BEM-device p= 0.0004, independent replicates = 2). All data are presented as mean ± SD. Statistical differences between the groups were determined
with unpaired two-tailed t-test (*p < 0.05, **p < 0.01, and ***p < 0.001). Source data are provided as a Source Data file.
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organoid culture with BEM-integrated microfluidics enables the
crucial features of human brain development that have been
limitedly demonstrated in the cerebral organoids previously
reported. Our bioengineered human cerebral organoids exhibit
structural, phenotypic, and functional features being observed
during whole human brain development as follows; (1) the
structural features of spontaneous brain morphogenesis (e.g.
widespread corticogenesis, organization of highly complex
structures with elongated cortical layers, apicobasal polarization
of radial organization, preplate splitting), (2) mature neuronal
identities (e.g. abundant expression of mature neuronal markers
(NeuN, VGLUT1, GAD, GABA), extensive neural networks (N-
cadherin), and synaptogenesis (SYNI, PSD95) at earlier time
points), (3) divergent brain cell population (e.g. radial glial cells,
microglia, astrocytes, excitatory/inhibitory neurons, Cajal-Retzius
cells), and (4) electrophysiologically active properties (e.g. sodium
current, multi-peaks of AP, postsynaptic current).
Although improvements in some of the cellular events and
features related to whole brain development have been demon-
strated in previously reported mature organoids engineered with
several technologies, to the best of our knowledge, there have
been few cerebral organoids simultaneously exhibiting all those
characteristics. For example, genetic modification of PSCs
increased NP proliferation and induced expansion and folding in
cerebral organoids, but delayed neuronal differentiation68. Syn-
thetic polymer fiber microfilaments generated cerebral organoids
with more continuous neuroepithelium20. However, the maturity
of engineered organoids was not confirmed in terms of mature
neuronal marker expression, folding structure, and electro-
physiological functionality. Moreover, the treatment of
CHIR99021, an exogenous patterning factor, led to more repro-
ducible forebrain formation rather than whole brain regions. As
our organoids do not involve any small molecules and solely rely
on spontaneous development in the presence of brain-specific
ECMs, they resemble more closely to the whole brain develop-
ment. Furthermore, the developmental processes were sig-
nificantly accelerated in our cerebral organoids than in previously
engineered organoids. In another study, supplementation of dif-
ferentiation medium with brain-derived neurotrophic factor
reduced cell death and improved cerebral organoid development
for an extended period19. However, the expression of mature
neuron and astrocyte markers (e.g. VGLUT1, vesicular GABA
transporter, GFAP) appeared only at 6 months. The SYNI+
neurons began to be expressed at 3 months. A recent study also
reported that the expression of mature neuronal markers,
including VGLUT1 and GAD1, was observed in 6-month-old
cerebral organoids69. In our study, such mature developmental
markers GAD1, GABA, and VGLUT1 were expressed in the
organoids at 45 days of culture (Supplementary Fig. 9d, h),
implying that combination of BEM and microfluidics shortened
the time for the appearance of excitatory and inhibitory neuronal
populations. In addition, GFAP and SYNI were detected at
60 days of culture (Fig. 6o, p), indicating that glial differentiation
and synaptogenesis which occur at a late state of brain develop-
ment might be accelerated by BEM-incorporated microfluidics.
Therefore, we believe that our engineered organoids show the
positive expression for excitatory and inhibitory neurons, astro-
cytes, and synapses at earlier time points than cerebral organoids
generated using previous technologies. The superiority of our
organoids may lie on the ability to recapitulate more rapidly
spontaneous development of whole human brain.
Early exposure of brain organoids to biochemical and bio-
physical cues provided by BEM facilitates the development of
brain organoids. We found that like Mat, BEM hydrogel is
retained for approximately 60~70 days of culture. The improve-
ments in BEM organoids at late time points after BEM disappears
are probably due to the prolonged effect of the signals from ECM
given at earlier days of culture. Brain region-specific organoid
development methods involve the use of patterning factors at an
early stage to specify progenitor fate. These factors are then
removed or minimized, and subsequent differentiation follows
intrinsic programs. Likewise, biochemical and biophysical cues of
ECM at early point seem to be critical because neuroepithelium
expansion occurs and fate of progenitors are specified at an early
stage of brain organoid development, which affects subsequent
maturation stages. In the future study, it may be preferable to
provide brain organoids with ECM microenvironments adjusted
to developmental stages by applying fetal BEM and adult BEM at
early and later time points of organoid culture, respectively. A
recent study to compare porcine fetal and adult brain ECMs
demonstrated that all types of ECM proteins were included in
both ECMs, but fetal brain-derived ECM contained higher con-
tents of fibrillin and biglycan70. Therefore, it would be important
to investigate any changes in ECM compositions in-depth during
brain development and reflect such ECM changes to different
stages of brain organoid culture.
A fine-tuned consistent dynamic flow provided by the BEM-
incorporated microfluidic device not only significantly reduced
the formation of the necrotic region and decreased apoptotic cell
death throughout the structures of cerebral organoids, but also
affected metabolic states and enhanced cell proliferation.
Although several methods have been applied to facilitate oxygen/
nutrient supply and waste exchange and reduce necrotic region in
organoids, our cerebral organoids engineered with BEM-
microfluidic device underwent improved structural, phenotypic,
and functional maturation compared to previously reported
cerebral organoids. A recent study adapted organotypic slice
culture at the air–liquid interface to cerebral organoids (ALI-CO),
leading to improved neuronal survival and axon outgrowth21.
However, because the organoids were cultured in slide sections,
the whole structure as well as the cortical layers of brain organoid
might not be well established. Another recent study generated
vascularized human cortical organoids by ectopically expressing
the vascular transcription factor in PSCs71. The presence of
functional vascular-like networks in the organoids alleviated the
apoptotic and hypoxic condition of the interior, and resulted in
higher incidences of APs, but there was marginal improvement in
cortical layer structure formation. This study examined maturity
of vascularized cortical organoids by analyzing SYNI expression
and incidence of AP. Our bioengineered organoids showed
positive expression of SYNI at earlier time point (Fig. 6o) and
higher incidence of APs (Fig. 7h). Miniaturized spinning bior-
eactors were developed to overcome some of the major limita-
tions of cerebral organoids (e.g. large batch-to-batch variability,
diffusional limitations of oxygen/nutrient, high cost, etc.)8, but
the study did not examine synaptogenesis and the development of
the organoids relied on region-specific differentiation protocols.
Cerebral organoids generated by our methodology showed posi-
tive expression for mature synaptic markers (SYNI, PSD95)
(Fig. 6o and Supplementary Fig. 16e). The presence of IBA1+
microglia (Supplementary Fig. 16a, b) indicates the diversity of
cell population in our cerebral organoids. Importantly, brain
organoids cultured in our microfluidic devices exhibited less
variation in terms of size and gene expression levels (Fig. 5k and
Supplementary Figs. 12a, 13e, f, 19, 20c, 22g) probably owing to
uniform flow of medium to reduce variation in culture condition,
demonstrating that microfluidic culture could improve the quality
control of organoids. Although BEM enhanced overall growth,
neuronal differentiation, cortical layer development, and elec-
trophysiological function of brain organoids, BEM alone did not
reduce the variation in the size of organoids in the orbital shaker
without the use of microfluidic device (Figs. 2b and 4c). As BEM-
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incorporated microfluidics could generate cerebral organoids
representing the development of the whole human brain with
reduced variability, our cerebral organoids could satisfy both
diversity and consistency in recapitulating brain development.
Due to the significant advantages of the microfluidic system as
an in vitro culture platform, a couple of studies have previously
demonstrated the application of chip systems for brain organoid
cultures22,23. For example, the commercially available millifluidic
system called Quasi Vivo increases oxygen transport, resulting in
an increased proportion of dopaminergic neurons in midbrain
organoids for up to 30 days of culture23. In another study, cer-
ebral organoid culture using a 5-channel chip23 was applied in
modeling neurodevelopmental disorders under chemical
exposure72. However, the syringe pump-based perfusion method
was employed for organoid culture in the chips, which decreases
the throughput for culture and analysis due to a need for addi-
tional equipment. In addition, only short-term cultures were
demonstrated in both studies where cortical layers and the radial
organization of cell populations were not observed in the orga-
noids. In contrast, our microfluidic chamber device was estab-
lished as a simple-to-use, pump-free perfusion-based microfluidic
culture platform. Cerebrospinal fluid-mimetic dynamic environ-
ments were achieved with a gravity-driven flow by laboratory
rocker. Our system not only takes the beneficial features of
microfluidic technologies, such as small-medium volumes, effec-
tive fluid exchanges, and precisely controlled fluid properties at
the microscale, but also overcomes the limitations of current
microfluidics for dynamic 3D cell cultures, including a low
throughput in culture and analysis, and a requirement for com-
plicated pumps, tubing, and expensive external devices.
Collectively, our organoid culture system based on combining
material biology and microfabrication technology enables the
generation of high-quality cerebral organoids with increased
reproducibility, throughput with reduced cost, and feasibility for
long-term 3D culture, providing a useful platform advancing the
organoid models for studying human organogenesis and dis-
orders. Our bioengineering strategy based on microfluidic brain
matrix would be more effective for generating cerebral organoids
that enable in vitro recapitulation of spontaneous whole brain
development processes than previously reported technologies,
while satisfying all important criteria of cerebral organoids,
including diversity, maturity, and consistency. The maturation of
cerebral organoids without involving exogenous morphogens and
genetic alteration would be regarded as a significant advancement
in cerebral organoid technology. As region-specific organoids
generated by guided methods with supplementation of exogenous
patterning factors have great potential for revealing the human-
specific aspects of particular brain regions, our culture platform
could be applied to modified cerebral organoid protocols with
added exogenous factors or regional organoids to expand its
applications for disease modeling and drug development in the
future. It would also be broadly applicable to other types of 3D
tissue organoid culture beyond the nervous system.
Methods
Preparation of the BEM. Human brain tissues were collected from the patients by
excision surgery (Supplementary Table 1) and stored at −80 °C until use. For the
use of human brain tissue for BEM preparation, informed consent was obtained
from the participants and the study with human brain tissue was approved by the
Institutional Review Board (IRB) (Permit Number: 4-2014-0769) of Yonsei Uni-
versity College of Medicine. Porcine brain tissues were obtained from the com-
mercial market. The decellularization of the brain tissue was conducted following
the protocol of our previous report53. The frozen brain tissues were slowly thawed,
and dura mater was carefully removed. Then, brain tissues were cut into small
pieces and agitated in buffer solutions in a consecutive order as follows: distilled
water (24 h, 60 rpm), 0.05% (v/v) trypsin/ethylenediaminetetraacetic acid (trypsin/
EDTA, #GIB-15400-054; Thermo Fisher Scientific, Waltham, MA, USA) (90 min at
37 °C, 60 rpm), 3% (v/v) Triton X-100 (#X100; Sigma-Aldrich, St. Louis, MO, USA)
(120 min), 1 M sucrose solution (#84097; Sigma-Aldrich) (30 min), distilled water
(15 min), 3% (v/w) sodium dodecyl sulfate (#71736; Sigma-Aldrich) (60 min, 150
rpm), 4% (v/v) ethanol (#E7023; Sigma-Aldrich) (120 min, 150 rpm), 1% (v/v)
Triton X-100 (#X100; Sigma-Aldrich) with 0.1% (v/v) ammonium hydroxide
(Sigma-Aldrich; #320145) (60 min), phosphate-buffered saline (PBS; Sigma-
Aldrich) (15 min), 1% (v/v) penicillin/streptomycin (P/S, #GIB-15140-122; Thermo
Fisher Scientific) (30 min, 60 rpm), distilled water (15 min, 90 rpm), and PBS
(15 min, 90 rpm). After the detergent treatments, decellularized tissues were
washed with distilled water thrice before preceding to the next step. All procedures
were performed at 4 °C and agitated at 120 rpm if not stated specifically. The
decellularized brain tissues were lyophilized and stored at 4 °C until use. BEM was
prepared by solubilizing decellularized brain tissue with 4 mg/ml pepsin (#P7000;
Sigma-Aldrich) in 0.02 M HCl and stirred at 120 rpm at room temperature for two
days. For organoid culture, a BEM solution of 40 mg/ml (w/v) concentration was
mixed with Matrigel (#354277; Corning Inc., Corning, NY, USA) to adjust the final
concentration to 400 μg/ml (w/v) BEM.
Fabrication of microfluidic device. The microfluidic device was fabricated by a
standard soft lithography technique. The mixture of poly(dimethylsiloxane)
(PDMS) pre-polymer solution (Dow Corning, Inc., Midland, MI, USA) and curing
agent (Sylgard® 184, Dow Corning, Inc.) at a ratio of 10:1 (v/v) was poured onto the
patterned master wafer with a 2.2 mm thickness to mold the microfluidic devices as
per the traditional replica molding process53. The details on the dimensions of the
microfluidic device are provided in Supplementary Fig. 2a. An 8-mm diameter
biopsy punch was used to punch holes into the chambers (Kai Industries Co., Ltd.,
Gifu, Japan). The samples were exposed to oxygen plasma (CUTE; Femto Science,
Seoul, Korea) to bond the PDMS layers. Two layers of the patterned PDMS were
stacked on top of each other, and a thin film of PDMS was bonded at the bottom as
a seal. For sterilization, the assembled devices were autoclaved and dried under
ultraviolet light before use.
Human iPSC maintenance. Human iPSC lines WT3 (kindly provided by the
Yonsei University School of Medicine) and KYOU-DXR0109B (#ACS-1023;
American Type Culture Collection, Manassas, VA, USA) were used. The use of
human iPSCs was approved by the Institutional Review Board (IRB) of Yonsei
University (Permit Number: 1040917-201510-BR-229-01E, 7001988-202104-BR-
1167-01E). The culture and maintenance of human iPSCs were conducted as
previously reported4,73. Human iPSCs were cultured in iPSC-maintaining medium
composed of Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F12 (DMEM/
F12, #11320-082; Thermo Fisher Scientific), 20% (v/v) Knockout Serum Replace-
ment (KSR, #10828-028; Thermo Fisher Scientific), 1% (v/v) penicillin-
streptomycin (P/S, #GIB-15140-122; Thermo Fisher Scientific), 1× non-essential
amino acid (NEAA, #GIB-11140-050; Thermo Fisher Scientific), 0.1 mM β-
mercaptoethanol (#63689-25ML-F; Sigma-Aldrich), and 10 ng/ml basic fibroblast
growth factor (bFGF, #4114-TC-01M; R&D System Inc., Minneapolis, MN, USA).
The cells were maintained on the feeder cell layers of 10 μg/ml (w/v) mitomycin C
(#M4287; Sigma-Aldrich)-treated STO fibroblasts (#CRL-1503; American Type
Culture Collection) and sub-cultured every seven days using 2 mg/ml (w/v) col-
lagenase type IV (#17104-019; Thermo Fisher Scientific). Human iPSCs were also
maintained in feeder-free conditions on Matrigel-coated plates and cultured in
mTeSRTM Plus medium (#100-0276; STEMCELL Technologies, Vancouver,
Canada).
Generation of brain organoids. Brain organoids were generated and cultured with
a slightly modified protocol from a previously described method by Lancaster
et al.3,4,20. Human iPSCs were detached from STO feeder layers by 2 mg/ml col-
lagenase type IV treatment for 30–45 min at 37 °C. Then, iPSC clumps were dis-
sociated by Accutase (#A1110501; Thermo Fisher Scientific) to generate single
cells. For human iPSCs cultured on Matrigel-coated plates, single-cell suspension
was prepared by trypLE (#12604013; Thermo Fisher Scientific) treatment. EBs were
generated by seeding 8,000 cells into a well of ultra-low-attachment 96-well plate
(#CLS7007, Corning Inc.). EBs generated from iPSCs cultured on the feeder layer
were cultured in iPSC-maintaining medium supplemented with 4 ng/ml bFGF
(#4114-TC-01M; R&D System Inc.) and 50 μM Rho-associated protein kinase
(ROCK) inhibitor (#Y0503; Sigma-Aldrich). EBs generated from feeder-free con-
ditions were cultured in Essential 8 medium (Thermo Fisher Scientific) and 50 μM
ROCK inhibitor. After 5–6 days of culture, the formed EBs were transferred into a
low-attachment Petri dish (21.5 cm2, #10060; SPL Life Sciences, Pocheon, Korea).
To induce the neuroepithelium-like structures, the EBs were cultured in suspension
in a neural induction medium composed of DMEM/F12 (#11320-082; Thermo
Fisher Scientific), 1× N2 supplement (#GIB-17502-048; Thermo Fisher Scientific),
1× Glutamax (#35050061; Thermo Fisher Scientific), 1× MEM-NEAA (#GIB-
11140-050; Thermo Fisher Scientific), and 1 mg/ml heparin (#H3149-10KU;
Sigma-Aldrich). The medium was exchanged daily for five days. At day 11, EBs
with neuroepithelium identity were encapsulated in 30 μl of Matrigel (#354277;
Corning Inc.) or BEM-supplemented Matrigel, and then transferred to a 24-well
plate (#CT-3526; Corning Inc.) and were further cultured in a differentiation
medium comprising DMEM/F12 (#11320-082; Thermo Fisher Scientific) and
Neurobasal (#GIB-21103-049; Thermo Fisher Scientific) (1:1) ratio supplemented
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with 1:200 (v/v) N2 supplement (#17502-048; Thermo Fisher Scientific), 1:100 (v/
v) B27 supplement without retinoic acid (#12587-010; Thermo Fisher Scientific),
1:100 (v/v) Glutamax (#35050061; Thermo Fisher Scientific), 1:200 (v/v) MEM-
NEAA (#GIB-11140-050; Thermo Fisher Scientific), 1:4000 (v/v) insulin (#I9278;
Sigma-Aldrich), and 3.5 μl/ml β-mercaptoethanol (#21985023; Sigma-Aldrich) for
four days. From day 15, the organoids encapsulated in Matrigel or BEM hydrogel
were cultured in a 60-mm dish on an orbital shaker (Mat organoid or BEM
organoid, respectively) (#NBT101SRC; BioTek, Winooski, VT, USA). The orga-
noids encapsulated in BEM hydrogel were also cultured in a well plate on a bi-
directional rocker (BEM-plate organoid) (IKA, #26-01270-01; Staufen, Germany).
The differentiation medium for the dynamic culture had the same composition,
except for the B27 supplement with retinoic acid (#17504-044; Thermo Fisher
Scientific). For the dynamic culture in the microfluidic device, a single organoid in
BEM hydrogel was transferred into each organoid culture chamber (one organoid
per chamber) in between the medium chambers (BEM-device organoid). The
culture chambers were then covered with a PDMS lid and placed on a bi-
directional rocker. Two organoids were cultured per device.
Microfilament-engineered cerebral organoids (enCORs) were generated as
previously reported20,74. In brief, coated VICRYL (polyglactin 910) suture (size 5-0,
Ethicon, Cincinnati, OH, USA) was mechanically sheared using a scalpel and cut
into 1-mm pieces. At day 13 (2 days after encapsulation into Matrigel or BEM
hydrogel), neural induction medium was replaced with differentiation medium.
CHIR99021 (3 μM, #C6556; LC Laboratory, Woburn, MA, USA) was added into
culture medium from day 13 to 15. For dynamic culture, enCORs in the dish were
moved onto an orbital shaker or enCORs in the microfluidic device were placed on
a rocking shaker.
Characterization of the BEM. Histological analysis of decellularized human brain
tissue was performed to confirm the removal of cellular components and the
preservation of ECM components. Decellularized human brain tissues were
embedded in the OCT compound (#HCP-0100-00A; CellPath, Hemel, Hempstead,
UK), frozen at −80 °C, and sectioned to 6 μm thickness. Hematoxylin and eosin
(H&E) and Masson’s Trichrome (MT) staining of the sectioned tissues were
conducted to identify the removal of cells and the presence of collagen, respectively.
To further verify the removal of cellular components, DNA was quantified in brain
tissue before and after decellularization. The total DNA was isolated using a DNA
extraction kit (#K-3032; Bioneer, Daejeon, Korea), according to the manufacturer’s
instructions, and the DNA content of each sample was determined by measuring
its absorbance at 260 nm on a microplate reader (Infinite M200 Pro, Tecan,
Maennedorf, Switzerland). The GAG content was measured in the native brain and
decellularized brain tissues using 1,9-dimethyl methylene blue dye solution
(#341088; Sigma-Aldrich, St. Louis, MO, USA) and chondroitin sulfate A (#C9819;
Sigma-Aldrich) as a standard, as previously described53.
Proteomic analysis. Proteomic analysis was performed on total 12 samples of
Matrigel (n= 1, biological replicate = 1), human BEM (n= 3, biological
replicates = 3), pBEM derived from porcine cortex (n= 4, biological replicates =
4), and pBEM derived from porcine cerebellum (n= 4, biological replicates = 4).
Proteomic analysis was performed using A Thermo Scientific Q Exactive Hybrid
Quadrupole-Orbitrap equipped with Dionex U 3000 RSLCnano HPLC system
(Thermo Fisher Scientific). The purified peptide sample was reconstituted in sol-
vent A (Water/Acetonitrile (98:2 v/v), 0.1% Formic acid), and then injected into
LC-nano ESI-MS/MS system. The sample was trapped in an Acclaim PepMap 100
trap column (100 μm × 2 cm, nanoViper C18, 5 μm, 100 Å, Thermo Fisher Sci-
entific) and washed for 6 min with 98% solvent A at a flow rate of 4 μl/minute, and
then separated on an Acclaim PepMap 100 capillary column (75 µm × 15 cm,
nanoViper C18, 3 µm, 100 Å, Thermo Fisher Scientific) at a flow rate of 300 nl/
minute. The LC gradient was run at 2 to 35% solvent B over 30 min, then from 35
to 90% over 10 min, followed by 90% solvent B for 5 min, and finally 5% solvent B
for 15 min. Xcaliber software version 3.1 was used to collect MS data. The Orbitrap
analyzer scanned precursor ions with a mass range of 350–1800m/z with 70,000
resolution at m/z 200. For collision-induced dissociation, up to the 15 most
abundant precursor ions were selected. The normalized collision energy was 32.
Mass data were acquired automatically using proteome discoverer 2.2 (Thermo
Fisher Scientific).
Protein identification was performed by Thermo Proteome Discoverer (version
2.4.1.15). Proteins were identified by searching MS and MS/MS data of peptides
against the Homo sapiens UniProt database (2020.10 release) for human BEM, Sus
scrofa UniProt database (2020.12 release) for pBEM, and Mus musculus UniProt
database (2020.12 release) for Matrigel. Trypsin was used as the protease for
cleavage and up to two missed cleavages were allowed. Carbamidomethylation of
cysteines was set as a static modification. Oxidation of methionine, N-terminal
acetylation, and N-terminal methionine excision were set as dynamic
modifications. Precursor mass tolerance was set to 10 ppm and fragment mass
tolerance was set to 0.02 Da. Proteins and peptides were filtered for false discovery
rate (FDR) less than 1%.
We compared the identified proteins in Matrigel and human BEM with an Atlas
of human brain-expressed genes75. The contents and composition of matrisome
proteins in Matrigel, human BEM, pBEM, and human brain tissue34 were
compared based on relative intensity-based absolute quantification (riBAQ) values,
which are approximately proportional to the molar amount of proteins present in
the matrices. Gene ontology biological process (GOBP) analysis76–78 was
performed on the proteins identified in BEM, but absent in Matrigel, which have at
least four-fold elevation of expression in human brain tissue compared to other
tissues35,78,79. For statistical significance, proteins and peptides were filtered for
FDR and p value less than 0.05. Raw p value was determined by Fisher’s exact test.
Histology and immunohistochemistry. At several time points in the organoid
culture (30, 45, 60, 75, 100, and 120 days), the brain organoids were fixed in 10%
formalin solution (#HT501640; Sigma-Aldrich) for one hour at room temperature,
washed twice using phosphate-buffered saline (PBS, Biosesang, Seongnam, Korea),
and immersed in 30% (w/v) sucrose dissolved in distilled water overnight at 4 °C
for cryoprotection. The organoids were embedded in OCT compound and frozen
at −80 °C. The samples were then sectioned in tissue slices of 20 μm thickness
using cryostat (Leica Inc., Wetzlar, Germany). For the histological analysis, the
tissue sections were examined with H&E staining to analyze the overall cellular
morphology and cavity in the organoids. For immunohistochemical staining, the
sectioned tissues were washed with PBS to remove excess OCT and permeabilized
with 0.2% (v/v) Triton X-100 (#X100; Sigma-Aldrich) in PBS for 20 min. Then, the
sections were treated with 4% (w/v) bovine serum albumin (#216006980; MP
Biomedicals, Santa Ana, CA, USA) and 2% (v/v) horse serum (#16050130; Thermo
Fisher Scientific) for one hour to block the non-specific binding of antibodies. The
samples were incubated with primary antibodies listed in Supplementary Table 6.
The stained samples were then washed with PBS three times and incubated with
Alexa Fluor 488 or 594-conjugated secondary antibodies (1:200; Thermo Fisher
Scientific) for signal visualization. The nuclei were counterstained with 4′,6-dia-
midino-2-phenylindole (DAPI, #A2412; TCI America, Portland, OR, USA) for 30
min and washed with PBS. The samples were mounted using a fluorescent
mounting medium (#H1400; Vector laboratories, Burlingame, CA, USA) and
observed under a confocal microscope (LSM 880, Carl Zeiss, Oberkochen,
Germany).
Image-based quantification. Fluorescence intensities of Tuj1 and MAP2 in the
whole section of organoids were measured by selecting the marker positive area
and using ‘Integrated density’ function in ‘set measurements’ setting in ImageJ. The
corrected total organoid fluorescence was calculated by the following equation;
Integrated density – (Area of selected cell × Mean fluorescence of background
readings). The area and perimeter of PAX6+ ventricle-like structures from 4
representative organoids were measured using ImageJ. The average number of cells
positive for SOX2, NeuN, TBR2, HOPX, IBA1, and CD68 per field was manually
counted using ImageJ. The average percentage ratio of cells positive for SOX2 per
field was quantified by manually counting the positively stained cells and dividing
them by the number of DAPI-stained nuclei. The positive areas for EthD1, Ki67,
FOXG1, and NeuN were determined by measuring the area stained positively for
markers and normalized to DAPI+ area using Image J. For Nestin+, cCASP3+,
HIF-1α+, VGLUT1+ area measurements, the area positively stained for each
marker was normalized to the total area of the image. The thickness of the cortical
plate, defined as the densely packed CTIP2+ regions, and the superficial layer
defined as the SATB2+ regions were measured using ImageJ. Three measurements
were taken at 45-degree angles to obtain the mean value.
qPCR analysis. The gene expression of the brain organoids at 30 and 75 days of
culturing was investigated using qPCR analysis, as previously described53,73. Total
RNA was isolated from approximately ten brain organoids per sample using an
RNA extraction kit (#9767 A; Takara Bio lnc., Kusatsu, Shiga, Japan) following the
manufacturer’s instructions. The RNA concentration was calculated by measuring
the absorbance of the samples at 260 nm using a spectrophotometer (Infinite M200
Pro, Tecan). The total RNA was reverse-transcribed into cDNA using a TaKaRa
PrimeScript II First-strand cDNA synthesis kit (#6110 A; TaKaRa Bio lnc.). The
synthesized cDNA was used for the qPCR reaction with the TaqMan Fast Universal
PCR MasterMix (#4366073; Thermo Fisher Scientific). The gene expression was
quantified with the Step One Plus Real-Time PCR system (Applied Biosystems,
Foster City, CA, USA) for the targets listed in Supplementary Table 7. TaqMan
Assay primers were purchased from Thermo Fisher Scientific. The relative gene
expression of each target was calculated by the comparative Ct method and nor-
malized using an endogenous reference glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). The gene expressions of the human brain organoids were compared
with human neural stem cells (NSCs, provided by Prof. Kook In Park at Yonsei
University College of Medicine) isolated from the brain tissue of a 13-week fetus
with full written parental consent and approval of the research ethics committee of
Yonsei University College of Medicine (protocol #4-2003-0078).
Tissue-specific ECM experiment. To investigate the tissue-specific effect of ECM
on brain organoid development, decellularized ECM derived from porcine organs,
including the brain (BEM), intestines (IEM), liver (LEM), and heart (HEM), was
tested for brain organoid culture. Decellularization of the porcine liver and heart
was performed as previously reported56. The porcine small intestine was decel-
lularized as follows: the intestine was thoroughly washed and cut laterally alongside
the intestinal wall so that it was in a flat, rectangular form. Then, it was cut into
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segments of 20 cm in length and agitated in the following solutions for the time
indicated: distilled water (24 h), decellularizing solution containing 1% (v/v) Triton
X-100 with 0.1% (v/v) ammonium hydroxide (#320145; Sigma-Aldrich) (48 h),
distilled water (24 h), 1% (v/v) penicillin/streptomycin (#GIB-15140-122; Thermo
Fisher Scientific) (1 h), and distilled water (1 h). All processes were performed at
4 °C and agitated at 120 rpm. The decellularized intestine tissues were lyophilized
and stored at 4 °C until use. The porcine brain was decellularized using the same
protocol for the human brain. At day 11, the EBs with neuroepithelium identity
were encapsulated in 30 μl Matrigel (#354277; Corning Inc., Corning, NY) or
decellularized ECM gel (0.4 mg/ml ECM+Matrigel) and cultured in 24-well plates
(Corning Inc.) in differentiation medium for four days. Then, 24-well plates
containing organoids were placed on a bi-directional rocker (#26-01270-01; IKA,
Staufen, Germany) for dynamic culture. At 30 days of culture, brain organoids were
analyzed by light microscope observation, immunostaining, and qPCR.
Calcium imaging. To examine the response of brain organoids to neuro-
transmitters, the organoids were incubated with the intracellular calcium indicator
2 μM Fluo-4 AM (#F14201; Thermo Fisher Scientific) for 40 min at 37 °C and
additionally for 30 min at 25 °C. Time-lapse changes of intracellular Ca2+ levels in
brain organoids were imaged after treatment with 100 μM glutamate (Sigma-
Aldrich) or 50 μM GABA (#A2129; Sigma-Aldrich). The cells in the treated
organoids were imaged every 3.725 s using a confocal microscope (LSM 880, Carl
Zeiss) at room temperature. The ZEN software (Carl Zeiss) was used to determine
the changes in the intensity of fluorescence. Briefly, the ROI was drawn around
individual cells identified by their morphology. The ΔF1/F0 trace for each ROI was
calculated by dividing the time-varying fluorescence by the initial baseline
fluorescence.
Synthesis and spectral characterizations of oxygen-sensing nanoparticles.
First, an amphiphilic precursor, urethane acrylate nonionomer (UAN), was syn-
thesized as reported previously60. The UAN precursor consisted of hydrophilic
polyethylene oxide (PEO; MW 1,500 g/mol) and hydrophobic polypropylene oxide
(PPO; MW 700 g/mol) segments that were linked covalently in a T-shape. To carry
out the polymerization of the UAN precursors via a radical reaction among their
vinyl groups, 10 g of UAN was dissolved in dimethyl sulfoxide (DMSO) to obtain a
homogeneous UAN-DMSO solution. After adding 0.02 g of azobisisobutyronitrile
(AIBN), a radical initiator, the temperature of the solution was slowly increased to
60 °C and maintained for three hours with gentle stirring. Polymerized UAN-DMSO
solution was named as poly(UAN) (PUAN)-DMSO solution. Then, 5.5 mg of the
oxygen-sensitive phosphor, Pt(II) meso-tetra(pentafluorophenyl)porphine (PtTFPP;
Frontier Scientific, Inc.), was added to 1.0mL of PUAN-DMSO solution which was
further diluted with DMSO to form a stock solution at a concentration of 1860 ppm.
PtTFPP-PUAN nanoparticles were formed via the nano-precipitation method80.
Briefly, the stock solution of PtTFPP-PUAN was dropped very slowly into PBS with
vigorous stirring at a volumetric 1:10 mixing ratio of PtTFPP-PUAN solution and
PBS. Because PtTFPP was immiscible in the aqueous phase, the oxygen-sensitive
phosphor remained partitioned within the hydrophobic core of PUAN
nanoparticles60 in the course of formation of micelle-like PUAN nanoparticles
dispersed in the aqueous PBS solution. The PtTFPP-PUAN stock solution in DMSO
can be stored at room temperature before forming nanoparticle suspensions.
To identify the excitation wavelength for the oxygen-sensing nanoparticles,
absorption was measured by exciting the PtTFPP-PUAN nanoparticle suspension
from 300 to 600 nm under both normoxic and deoxygenated conditions. Gentle
bubbling with N2 gas into the nanoparticle suspension (<1 ml) contained in a 15 ml
conical tube for 30 min allowed for complete deoxygenation of the nanoparticle
suspension. Immediately after N2-bubbling, the deoxygenated nanoparticle
suspension was transferred into a 96-well plate (50 μl/well), and excitation spectra
were acquired at room temperature using a microplate reader (Infinite 200 Pro,
Tecan). Similarly, the emission spectra under the normoxic and deoxygenated
conditions were also obtained by measuring the phosphorescence intensity of the
oxygen-sensing nanoparticles from 600 to 850 nm with 430 nm as a fixed excitation
wavelength. Based on the Stern–Volmer equation, the relative phosphorescence
intensity, which is represented by phosphorescence under the deoxygenated
condition (I0) divided by phosphorescence (I), is linearly proportional to oxygen
(i.e. quencher) concentration60.
Measurement of oxygen levels in brain organoids. To monitor the oxygen levels
within organoids, the oxygen-sensing nanoparticles were allowed to diffuse into the
brain organoids by incubating the organoids in the medium containing the
PtTFPP-PUAN nanoparticles at 37 °C overnight. The stock PtTFPP-PUAN solu-
tion in DMSO was pre-mixed with the culture medium at a ratio of 1:1 (v/v). Then,
nanoparticle-incorporated brain organoids were rinsed with Dulbecco’s PBS
(#D5652; Sigma-Aldrich) before analysis. The working principle of the optical
measurement of the oxygen level is as follows. Upon photoexcitation of the oxygen-
sensitive phosphor (i.e. PtTFPP) encapsulated within the PUAN nanoparticles at
430 nm, electrons in PtTFPP become excited in the triplet state. As these electrons
in the excited triplet state fall into the ground singlet state, PtTFPP emits phos-
phorescence. When oxygen molecules are abundant around the excited PtTFPP
(e.g. high oxygen concentration), random collisions between the oxygen molecules
and the excited PtTFPP lead to energy transfer to oxygen; thus, such PtTFPP is no
longer capable of emitting phosphorescence. This process is called dynamic
quenching, which explains why high oxygen levels result in low phosphorescence
intensity. The phosphorescence of PtTFPP-PUAN nanoparticles incorporated
within the brain organoids was observed at 754 nm while exciting at 430 nm on a
laser scanning confocal microscope (LSM 880, Carl Zeiss). The ZEN microscope
software was used to measure the intensity of phosphorescence signals. The mean
phosphorescence intensity of the BEM-device group was normalized to that of the
BEM-plate group using Zen software.
Tissue clearing and imaging of whole 3D brain organoids. Brain organoids were
cleared using Clear, Unobstructed Brain Imaging Cocktails, and Computational
analysis (CUBIC) using the following protocol81; the organoids were incubated
with 4% paraformaldehyde (Sigma-Aldrich) at 4 °C overnight. The fixed samples
were then immersed in modified ScaleCUBIC-1 solution consisting of 10% (w/w)
Triton X-100, 5% (w/w) NNNN-tetrakis (2-HP) ethylenediamine, 10% (w/w) urea,
and distilled water for three days at 37 °C, and washed with PBS three times at
room temperature. Cleared brain organoid samples were analyzed by immuno-
histochemical staining for confocal microscopy imaging. The samples were incu-
bated with primary antibodies for three days at room temperature, washed at least
three times with PBS, incubated with secondary antibodies labeled with Alexa
Fluor-conjugated 488 or 594 for two days at room temperature, and counterstained
with DAPI for nucleus staining. For light-sheet microscopic imaging, the nuclei of
the samples were stained with Syto16 (Thermo Fisher Scientific). The samples were
incubated in ScaleCUBIC-2 solution [25% (w/w) urea, 50% (w/w) sucrose, 10% (w/
w) triethanolamine, and distilled water] for 24 h to improve transparency, mounted
with the same solution, and visualized on a confocal microscope (LSM 880, Carl
Zeiss and Ni-E upright microscope +A1, Nikon, Tokyo, Japan) or light-sheet
microscope (Zeiss Z1, Carl Zeiss). The 3D reconstruction and analysis of the
images were performed using the IMARIS program (version 9.2, Oxford Instru-
ments, Abingdon, UK). To visualize the 3D surface of brain organoids, 3D stack
images were modified using the normal shading view. The location of TBR1+ cells
was analyzed using a spot tool. The volume and sphericity of the organoids were
measured using a surface tool
Electrophysiology. The whole-cell patch-clamp recording was performed as pre-
viously described10. During recording, brain organoids were submerged and con-
tinuously perfused with an artificial cerebrospinal fluid (aCSF) consisting of (in
mM): 119 NaCl, 2.5 KCl, 11 glucose, 26 NaHCO3, 1.25 NaH2PO4, 2.5 CaCl2, and
1.3 MgCl2 saturated with 95% O2 and 5% CO2 at 30–32 °C. Recording glass pip-
ettes (2–4 MΩ) were filled with an intracellular solution containing (in mM): 135
potassium methanesulfonate, 10 KCl, 10 HEPES, 1 EGTA, and 2 Na2ATP (pH 7.2
to 7.4 adjusted with KOH). The whole-cell recordings were performed using an
upright microscope (BX51WI, Olympus, Tokyo, Japan) with IR-DIC optics. Signals
were recorded using a MultiClamp 700B amplifier, filtered at 3 kHz using a Bessel
filter, and digitized at 10 kHz with a Digidata 1550B analog-to-digital board
(Molecular Devices, Sunnyvale, CA, USA). To measure Na+ currents, cells were
subjected to a series of voltage steps (1000 msec duration) from −30 to +20 mV (in
10 mV increments) at a holding potential of −60 mV in voltage-clamp mode. We
measured the resting membrane potential, and then a series of current pulses (500
msec) with increasing amplitude between −5 pA and +25 pA (in 5 pA steps) were
applied to evoke APs. The AP threshold was defined as the somatic voltage at
which dV/dt exceeds 20 V/s. Synaptic currents were acquired from a neuron at a
resting membrane potential (−60 mV).
RNA-sequencing analysis. Brain organoids in each condition (Mat-plate, BEM-
plate, BEM-device) were collected at the indicated time points (n= 3). For sample
preparation, 5~10 organoids were collected from the 3D matrix per one batch of
samples for each experimental condition. RNA was isolated using an RNA
extraction kit (Takara Bio Inc.) according to the manufacturer’s instructions. RNA
concentrations were measured using a NanoDrop8000 spectrophotometer (#ND-
8000-GL; Thermo Fisher Scientific), and total RNA integrity was checked using an
Agilent Technologies 2100 Bioanalyzer (#G2939BA; Agilent, Santa Clara, CA,
USA). RNA was enriched for mRNA sequencing using an Illumina Truseq
stranded mRNA library prep kit (#20020595; Illumina, San Diego, CA, USA).
mRNA was enriched by poly-T oligo-attached magnetic beads (Truseq stranded
mRNA library prep kit, Illumina) with two rounds of the purification process and
fragmented from at least 1 μg of total RNA. Fragments of cleaved RNA which were
primed with random hexamers were reverse-transcribed into the first strand of
cDNA using reverse transcriptase (SuperScript™ II Reverse Transcriptase,
#18064014; Thermo Fisher Scientific) in the presence of random primers. After-
ward, a single ‘A’ nucleotide was attached to the 3′ ends of the cDNA fragments,
and the adapter was subsequently ligated. To create the final strand-specific cDNA
library, the samples were purified and amplified by PCR. The quality of the enri-
ched cDNA libraries was verified by capillary electrophoresis (Bioanalyzer, Agi-
lent). Subsequently, cDNA libraries were combined with a SYBR Green PCR
MasterMix system (#4364346; Applied Biosystems) to present each value at
equimolar concentration in the pool. A cBot 2 automated system (#SY-312-2001;
Illumina) was used for the cluster generation of barcoded samples, which were
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applied for sequencing by synthesis on a HISEQ 2500 sequencing system (Illu-
mina) with 100 bp length. The reads were aligned with Tophat 13 (v2.0.13; http://
ccb.jhu.edu/software/tophat/) to map the reads and to calculate the expression
levels between samples and a reference genome (human genome: hg19). To observe
the differentially expressed genes (DEGs), aligned reads were analyzed by Cuffdiff
(v2.2.0; http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/). Then, to visualize
RNA-sequencing data, Cuffdiff data were loaded to CummeRbund (v2.8.2; http://
compbio.mit.edu/cummeRbund/manual_2_0.html). Aligned reads of the control
and cases were subjected to fragments per kilobase of transcript per million
(FPKM) estimation with Cufflinks (v1.3.0).
For the comparison of organoids in several brain regions (dorsolateral
prefrontal cortex, ventrolateral prefrontal cortex, orbital frontal cortex, cerebellar
cortex, hippocampus, cerebellum, striatum, and mediodorsal nucleus of the
thalamus), the FPKM expression values of Brainspan were downloaded from the
Allen BrainSpan human transcriptome dataset (http://www.brainspan.org/static/
download.html). FPKM values were filtered for differential expression and joined
with the Brainspan via the gene symbols. The similarity of expression was
compared by the rank of the expressed gene via Pearson’s correlation. Pearson’s
correlation coefficients between brain organoid samples and brain regions from
fetal to adult stages were expressed as a heatmap.
GO term enrichment analysis was performed on genes with adjusted p-values <
0.05 that were considered to be significantly differentially expressed in comparison
to the control group using the DAVID program (http://david.abcc.ncifcrf.gov) to
obtain a comprehensive set of functional annotation.
GSEA was performed using brain tissue-related gene lists19,82–87 against
normalized RNA-seq reads of Mat and BEM organoids samples with gene sets of
15 to 500 components included in the analysis using Broad Institute GSEA
software. The weighted scoring scheme with a default parameter of other criteria
was applied, and filtered gene sets were significantly enriched (p-value < 0.01).
To find disease-related term enrichment, the DAVID algorithm with GAD
(Genetic Association Database) DISEASE term was utilized. Based on the
upregulated gene list between the BEM-plate versus BEM-device organoid datasets
with P-values < 0.05, the results of the functional annotation chart were checked
and the GAD DISEASE related term with P-values < 0.01 was observed.
To check the overlap of differentially expressed genes among brain organoids
under different culture conditions with known disease-related genes, BrainSpan
datasets were utilized. The statistical significance of the overlap between the two
groups of genes was calculated with Perl scripts in the online tool (http://nemates.
org/MA/progs/overlap_stats.html). Disease-related terms showing significant
overlapping with upregulated or downregulated gene lists in the BEM-plate versus
BEM-device group datasets were the primary focus.
Computational simulation of glucose concentration. A computational program
was applied to simulate the glucose levels in brain organoids grown in the plate and
microfluidic device. The model simulated the coupled convection‐diffusion and
single‐phase flow, governed by Brinkman equations and Navier–Stokes equations.
All simulations were performed using a commercial finite element solver in
COMSOL Multiphysics software (COMSOL Inc., Burlington, MA, USA). The
factors used in this simulation are listed in Supplementary Table 5. To simulate the
gravity‐driven flow generated by the axial rocker, the boundary condition of the
inlet was set to be sinusoidal pressure deriving back and forth flow with a max-
imum flow rate of 1.63 µl s−1. Since the microfluidic device has a symmetrical
design, only half of the device with a symmetry boundary on its axis was simulated.
Glucose and lactate measurements. Quantification of glucose level in brain
organoids and lactate level secreted from organoids to culture medium was per-
formed using a glucose assay kit (Abcam) and a lactate assay kit (Abcam),
respectively, according to the manufacturer’s instructions.
Necrotic area measurement. To compare necrotic area in brain organoids cultured
in different conditions, the cells in organoids were exposed to ethidium homodimer-1
(Thermo Fisher Scientific) for 1 h at 37 °C and fixed in 10% formalin solution for 1 h.
The samples were then incubated with DAPI overnight at 4 °C. The signals of dead
cells and nuclear stain were imaged using a confocal microscopy (LSM 880).
Statistical analysis. Quantitative data are described as mean ± standard deviation
(SD) for n ≥ 3. Statistical significance between the control and experimental groups
was determined as previously described53,73. Statistical analysis was performed
using the two-tailed unpaired Student’s t test using GraphPad Prism 8 software
(GraphPad Software, San Diego, CA, USA). P values lower than 0.05 were con-
sidered statistically significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data generated in this study have been deposited in
the ProteomeXchange Consortium via the PRIDE partner repository88 with the dataset
identifier “PXD025397”. The RNA-sequencing data generated in this study are available
in the NCBI Gene Expression Omnibus (GEO) under accession code “GSE145386”.
Source data are provided with this paper. Raw data for all figures and p values for
supplementary figures are provided in Source Data file. Lists of total proteins and
proteins that are known to be enriched in human brain tissues in all samples identified by
proteomic analysis are also provided in Source Data file. The reference datasets of brain
regions used for comparison are available in the Allen BrainSpan human transcriptome
dataset [www.brainspan.org/static/download.html]. The protein samples were identified
by searching MS and MS/MS data of peptides against the homo sapiens UniProt database
(2020.10 release) for human BEM, Sus scrofa UniProt database (2020.12 release) for
pBEM, andMus musculus UniProt database (2020.12 release) for Mat. Proteins identified
in Mat and human BEM were compared with the datasets in the Human Protein Atlas
portal [www.proteinatlas.org]. The contents and composition of matrisome proteins in
human brain tissues were analyzed from the data in the Human Proteome Map [www.
humanproteomemap.org]. All datasets generated during the current study are available
from the corresponding author on reasonable request. Source data are provided with
this paper.
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